1 | | GO:0008152 | metabolic process | 113 | 913 | 843 | 24411 | 3.41e-26 | 0.11 | 0.03 | 3.3 |
2 | | GO:0006468 | protein amino acid phosphorylation | 98 | 928 | 694 | 24560 | 2.86e-24 | 0.10 | 0.03 | 3.5 |
3 | | GO:0001666 | response to hypoxia | 36 | 990 | 74 | 25180 | 8.79e-24 | 0.04 | 0.00 | 12.0 |
4 | | GO:0007165 | signal transduction | 200 | 826 | 2316 | 22938 | 5.01e-23 | 0.19 | 0.09 | 2.1 |
5 | | GO:0006118 | electron transport | 70 | 956 | 386 | 24868 | 7.05e-23 | 0.07 | 0.02 | 4.5 |
6 | | GO:0006915 | apoptosis | 73 | 953 | 421 | 24833 | 8.36e-23 | 0.07 | 0.02 | 4.3 |
7 | | GO:0006954 | inflammatory response | 58 | 968 | 282 | 24972 | 1.96e-21 | 0.06 | 0.01 | 5.1 |
8 | | GO:0008284 | positive regulation of cell proliferation | 53 | 973 | 242 | 25012 | 9.53e-21 | 0.05 | 0.01 | 5.4 |
9 | | GO:0008283 | cell proliferation | 63 | 963 | 353 | 24901 | 2.17e-20 | 0.06 | 0.01 | 4.4 |
10 | | GO:0006091 | generation of precursor metabolites and energy | 36 | 990 | 101 | 25153 | 3.55e-20 | 0.04 | 0.00 | 8.8 |
11 | | GO:0007267 | cell\-cell signaling | 62 | 964 | 349 | 24905 | 5.37e-20 | 0.06 | 0.01 | 4.4 |
12 | | GO:0006916 | anti\-apoptosis | 44 | 982 | 170 | 25084 | 8.48e-20 | 0.04 | 0.01 | 6.4 |
13 | | GO:0006629 | lipid metabolic process | 59 | 967 | 342 | 24912 | 1.49e-18 | 0.06 | 0.01 | 4.2 |
14 | | GO:0006955 | immune response | 78 | 948 | 581 | 24673 | 2.40e-18 | 0.08 | 0.02 | 3.3 |
15 | | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 46 | 980 | 210 | 25044 | 3.53e-18 | 0.04 | 0.01 | 5.4 |
16 | | GO:0006979 | response to oxidative stress | 33 | 993 | 104 | 25150 | 2.30e-17 | 0.03 | 0.00 | 7.8 |
17 | | GO:0006006 | glucose metabolic process | 25 | 1001 | 52 | 25202 | 7.70e-17 | 0.02 | 0.00 | 11.8 |
18 | | GO:0007155 | cell adhesion | 81 | 945 | 729 | 24525 | 1.51e-14 | 0.08 | 0.03 | 2.7 |
19 | | GO:0008285 | negative regulation of cell proliferation | 43 | 983 | 243 | 25011 | 3.29e-14 | 0.04 | 0.01 | 4.4 |
20 | | GO:0001525 | angiogenesis | 29 | 997 | 106 | 25148 | 4.90e-14 | 0.03 | 0.00 | 6.7 |
21 | | GO:0006810 | transport | 92 | 934 | 919 | 24335 | 5.96e-14 | 0.09 | 0.04 | 2.5 |
22 | | GO:0006508 | proteolysis | 71 | 955 | 614 | 24640 | 7.75e-14 | 0.07 | 0.02 | 2.8 |
23 | | GO:0043066 | negative regulation of apoptosis | 26 | 1000 | 85 | 25169 | 1.15e-13 | 0.03 | 0.00 | 7.5 |
24 | | GO:0042981 | regulation of apoptosis | 30 | 996 | 121 | 25133 | 1.61e-13 | 0.03 | 0.00 | 6.1 |
25 | | GO:0006928 | cell motility | 32 | 994 | 144 | 25110 | 3.29e-13 | 0.03 | 0.01 | 5.5 |
26 | | GO:0006917 | induction of apoptosis | 32 | 994 | 159 | 25095 | 3.31e-12 | 0.03 | 0.01 | 5.0 |
27 | | GO:0006099 | tricarboxylic acid cycle | 16 | 1010 | 28 | 25226 | 3.87e-12 | 0.02 | 0.00 | 14.1 |
28 | | GO:0043123 | positive regulation of I\-kappaB kinase/NF\-kappaB cascade | 27 | 999 | 112 | 25142 | 4.58e-12 | 0.03 | 0.00 | 5.9 |
29 | | GO:0006631 | fatty acid metabolic process | 24 | 1002 | 94 | 25160 | 2.53e-11 | 0.02 | 0.00 | 6.3 |
30 | | GO:0007507 | heart development | 27 | 999 | 124 | 25130 | 3.44e-11 | 0.03 | 0.00 | 5.4 |
31 | | GO:0006096 | glycolysis | 21 | 1005 | 72 | 25182 | 5.52e-11 | 0.02 | 0.00 | 7.2 |
32 | | GO:0007166 | cell surface receptor linked signal transduction | 33 | 993 | 193 | 25061 | 7.04e-11 | 0.03 | 0.01 | 4.2 |
33 | | GO:0007242 | intracellular signaling cascade | 51 | 975 | 444 | 24810 | 3.33e-10 | 0.05 | 0.02 | 2.8 |
34 | | GO:0006094 | gluconeogenesis | 13 | 1013 | 23 | 25231 | 4.55e-10 | 0.01 | 0.00 | 13.9 |
35 | | GO:0007049 | cell cycle | 57 | 969 | 541 | 24713 | 6.31e-10 | 0.06 | 0.02 | 2.6 |
36 | | GO:0005975 | carbohydrate metabolic process | 39 | 987 | 288 | 24966 | 6.57e-10 | 0.04 | 0.01 | 3.3 |
37 | | GO:0019221 | cytokine and chemokine mediated signaling pathway | 17 | 1009 | 51 | 25203 | 6.86e-10 | 0.02 | 0.00 | 8.2 |
38 | | GO:0008217 | regulation of blood pressure | 18 | 1008 | 61 | 25193 | 1.11e-09 | 0.02 | 0.00 | 7.3 |
39 | | GO:0030324 | lung development | 19 | 1007 | 70 | 25184 | 1.25e-09 | 0.02 | 0.00 | 6.7 |
40 | | GO:0042744 | hydrogen peroxide catabolic process | 11 | 1015 | 16 | 25238 | 2.24e-09 | 0.01 | 0.00 | 16.9 |
41 | | GO:0009887 | organ morphogenesis | 27 | 999 | 155 | 25099 | 2.62e-09 | 0.03 | 0.01 | 4.3 |
42 | | GO:0008286 | insulin receptor signaling pathway | 14 | 1012 | 36 | 25218 | 4.42e-09 | 0.01 | 0.00 | 9.6 |
43 | | GO:0007268 | synaptic transmission | 34 | 992 | 246 | 25008 | 5.14e-09 | 0.03 | 0.01 | 3.4 |
44 | | GO:0007050 | cell cycle arrest | 21 | 1005 | 98 | 25156 | 6.60e-09 | 0.02 | 0.00 | 5.3 |
45 | | GO:0007596 | blood coagulation | 24 | 1002 | 134 | 25120 | 1.24e-08 | 0.02 | 0.01 | 4.4 |
46 | | GO:0006633 | fatty acid biosynthetic process | 15 | 1011 | 48 | 25206 | 1.42e-08 | 0.01 | 0.00 | 7.7 |
47 | | GO:0009611 | response to wounding | 13 | 1013 | 34 | 25220 | 1.86e-08 | 0.01 | 0.00 | 9.4 |
48 | | GO:0015758 | glucose transport | 12 | 1014 | 30 | 25224 | 4.40e-08 | 0.01 | 0.00 | 9.8 |
49 | | GO:0006520 | amino acid metabolic process | 16 | 1010 | 62 | 25192 | 4.59e-08 | 0.02 | 0.00 | 6.4 |
50 | | GO:0042493 | response to drug | 17 | 1009 | 72 | 25182 | 5.35e-08 | 0.02 | 0.00 | 5.8 |
51 | | GO:0007605 | sensory perception of sound | 25 | 1001 | 161 | 25093 | 7.47e-08 | 0.02 | 0.01 | 3.8 |
52 | | GO:0030593 | neutrophil chemotaxis | 10 | 1016 | 19 | 25235 | 8.02e-08 | 0.01 | 0.00 | 13.0 |
53 | | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 19 | 1007 | 95 | 25159 | 8.90e-08 | 0.02 | 0.00 | 4.9 |
54 | | GO:0006874 | cellular calcium ion homeostasis | 16 | 1010 | 66 | 25188 | 9.61e-08 | 0.02 | 0.00 | 6.0 |
55 | | GO:0006950 | response to stress | 23 | 1003 | 141 | 25113 | 1.12e-07 | 0.02 | 0.01 | 4.0 |
56 | | GO:0006635 | fatty acid beta\-oxidation | 11 | 1015 | 27 | 25227 | 1.39e-07 | 0.01 | 0.00 | 10.0 |
57 | | GO:0006461 | protein complex assembly | 26 | 1000 | 181 | 25073 | 1.64e-07 | 0.03 | 0.01 | 3.5 |
58 | | GO:0045449 | regulation of transcription | 40 | 986 | 373 | 24881 | 2.07e-07 | 0.04 | 0.01 | 2.6 |
59 | | GO:0040018 | positive regulation of multicellular organism growth | 10 | 1016 | 22 | 25232 | 2.32e-07 | 0.01 | 0.00 | 11.2 |
60 | | GO:0006801 | superoxide metabolic process | 8 | 1018 | 11 | 25243 | 2.70e-07 | 0.01 | 0.00 | 17.9 |
61 | | GO:0051384 | response to glucocorticoid stimulus | 10 | 1016 | 23 | 25231 | 3.21e-07 | 0.01 | 0.00 | 10.7 |
62 | | GO:0006809 | nitric oxide biosynthetic process | 9 | 1017 | 17 | 25237 | 3.49e-07 | 0.01 | 0.00 | 13.0 |
63 | | GO:0007565 | female pregnancy | 15 | 1011 | 65 | 25189 | 4.15e-07 | 0.01 | 0.00 | 5.7 |
64 | | GO:0006879 | cellular iron ion homeostasis | 11 | 1015 | 31 | 25223 | 4.29e-07 | 0.01 | 0.00 | 8.7 |
65 | | GO:0043406 | positive regulation of MAP kinase activity | 8 | 1018 | 12 | 25242 | 4.35e-07 | 0.01 | 0.00 | 16.4 |
66 | | GO:0001836 | release of cytochrome c from mitochondria | 9 | 1017 | 18 | 25236 | 5.05e-07 | 0.01 | 0.00 | 12.3 |
67 | | GO:0008203 | cholesterol metabolic process | 14 | 1012 | 57 | 25197 | 5.28e-07 | 0.01 | 0.00 | 6.0 |
68 | | GO:0006935 | chemotaxis | 27 | 999 | 207 | 25047 | 5.35e-07 | 0.03 | 0.01 | 3.2 |
69 | | GO:0008635 | caspase activation via cytochrome c | 7 | 1019 | 8 | 25246 | 6.62e-07 | 0.01 | 0.00 | 21.5 |
70 | | GO:0006749 | glutathione metabolic process | 8 | 1018 | 13 | 25241 | 6.79e-07 | 0.01 | 0.00 | 15.1 |
71 | | GO:0043524 | negative regulation of neuron apoptosis | 10 | 1016 | 26 | 25228 | 7.93e-07 | 0.01 | 0.00 | 9.5 |
72 | | GO:0045786 | negative regulation of cell cycle | 21 | 1005 | 138 | 25116 | 1.08e-06 | 0.02 | 0.01 | 3.7 |
73 | | GO:0001501 | skeletal development | 20 | 1006 | 129 | 25125 | 1.50e-06 | 0.02 | 0.01 | 3.8 |
74 | | GO:0030198 | extracellular matrix organization and biogenesis | 12 | 1014 | 46 | 25208 | 2.00e-06 | 0.01 | 0.00 | 6.4 |
75 | | GO:0045941 | positive regulation of transcription | 17 | 1009 | 98 | 25156 | 2.37e-06 | 0.02 | 0.00 | 4.3 |
76 | | GO:0006936 | muscle contraction | 17 | 1009 | 99 | 25155 | 2.68e-06 | 0.02 | 0.00 | 4.2 |
77 | | GO:0006839 | mitochondrial transport | 10 | 1016 | 31 | 25223 | 2.93e-06 | 0.01 | 0.00 | 7.9 |
78 | | GO:0042632 | cholesterol homeostasis | 10 | 1016 | 31 | 25223 | 2.93e-06 | 0.01 | 0.00 | 7.9 |
79 | | GO:0050730 | regulation of peptidyl\-tyrosine phosphorylation | 7 | 1019 | 11 | 25243 | 2.95e-06 | 0.01 | 0.00 | 15.7 |
80 | | GO:0008632 | apoptotic program | 8 | 1018 | 17 | 25237 | 3.14e-06 | 0.01 | 0.00 | 11.6 |
81 | | GO:0006919 | caspase activation | 11 | 1015 | 41 | 25213 | 4.23e-06 | 0.01 | 0.00 | 6.6 |
82 | | GO:0008015 | blood circulation | 13 | 1013 | 61 | 25193 | 5.21e-06 | 0.01 | 0.00 | 5.2 |
83 | | GO:0007608 | sensory perception of smell | 2 | 1024 | 445 | 24809 | 5.82e-06 | 0.00 | 0.02 | 0.1 |
84 | | GO:0050728 | negative regulation of inflammatory response | 8 | 1018 | 19 | 25235 | 6.01e-06 | 0.01 | 0.00 | 10.4 |
85 | | GO:0008625 | induction of apoptosis via death domain receptors | 7 | 1019 | 13 | 25241 | 6.72e-06 | 0.01 | 0.00 | 13.3 |
86 | | GO:0006953 | acute\-phase response | 10 | 1016 | 35 | 25219 | 7.23e-06 | 0.01 | 0.00 | 7.0 |
87 | | GO:0042593 | glucose homeostasis | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
88 | | GO:0030574 | collagen catabolic process | 9 | 1017 | 27 | 25227 | 7.39e-06 | 0.01 | 0.00 | 8.2 |
89 | | GO:0001503 | ossification | 14 | 1012 | 74 | 25180 | 7.62e-06 | 0.01 | 0.00 | 4.7 |
90 | | GO:0042554 | superoxide release | 6 | 1020 | 8 | 25246 | 8.00e-06 | 0.01 | 0.00 | 18.5 |
91 | | GO:0043491 | protein kinase B signaling cascade | 6 | 1020 | 8 | 25246 | 8.00e-06 | 0.01 | 0.00 | 18.5 |
92 | | GO:0010033 | response to organic substance | 8 | 1018 | 20 | 25234 | 8.13e-06 | 0.01 | 0.00 | 9.8 |
93 | | GO:0048661 | positive regulation of smooth muscle cell proliferation | 7 | 1019 | 14 | 25240 | 9.74e-06 | 0.01 | 0.00 | 12.3 |
94 | | GO:0007275 | multicellular organismal development | 73 | 953 | 1029 | 24225 | 1.07e-05 | 0.07 | 0.04 | 1.7 |
95 | | GO:0000060 | protein import into nucleus\, translocation | 8 | 1018 | 21 | 25233 | 1.08e-05 | 0.01 | 0.00 | 9.4 |
96 | | GO:0016525 | negative regulation of angiogenesis | 8 | 1018 | 21 | 25233 | 1.08e-05 | 0.01 | 0.00 | 9.4 |
97 | | GO:0000187 | activation of MAPK activity | 12 | 1014 | 56 | 25198 | 1.14e-05 | 0.01 | 0.00 | 5.3 |
98 | | GO:0032496 | response to lipopolysaccharide | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
99 | | GO:0008354 | germ cell migration | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
100 | | GO:0006729 | tetrahydrobiopterin biosynthetic process | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
101 | | GO:0042104 | positive regulation of activated T cell proliferation | 6 | 1020 | 9 | 25245 | 1.29e-05 | 0.01 | 0.00 | 16.4 |
102 | | GO:0030036 | actin cytoskeleton organization and biogenesis | 18 | 1008 | 126 | 25128 | 1.36e-05 | 0.02 | 0.00 | 3.5 |
103 | | GO:0016477 | cell migration | 11 | 1015 | 48 | 25206 | 1.53e-05 | 0.01 | 0.00 | 5.6 |
104 | | GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 22 | 1004 | 181 | 25073 | 1.61e-05 | 0.02 | 0.01 | 3.0 |
105 | | GO:0015992 | proton transport | 14 | 1012 | 80 | 25174 | 1.66e-05 | 0.01 | 0.00 | 4.3 |
106 | | GO:0001658 | ureteric bud branching | 7 | 1019 | 16 | 25238 | 1.92e-05 | 0.01 | 0.00 | 10.8 |
107 | | GO:0007172 | signal complex assembly | 6 | 1020 | 10 | 25244 | 2.00e-05 | 0.01 | 0.00 | 14.8 |
108 | | GO:0018108 | peptidyl\-tyrosine phosphorylation | 7 | 1019 | 17 | 25237 | 2.62e-05 | 0.01 | 0.00 | 10.1 |
109 | | GO:0050796 | regulation of insulin secretion | 6 | 1020 | 11 | 25243 | 2.98e-05 | 0.01 | 0.00 | 13.4 |
110 | | GO:0051592 | response to calcium ion | 6 | 1020 | 11 | 25243 | 2.98e-05 | 0.01 | 0.00 | 13.4 |
111 | | GO:0007595 | lactation | 8 | 1018 | 25 | 25229 | 3.05e-05 | 0.01 | 0.00 | 7.9 |
112 | | GO:0006968 | cellular defense response | 15 | 1011 | 97 | 25157 | 3.07e-05 | 0.01 | 0.00 | 3.8 |
113 | | GO:0019395 | fatty acid oxidation | 5 | 1021 | 6 | 25248 | 3.41e-05 | 0.00 | 0.00 | 20.5 |
114 | | GO:0007585 | respiratory gaseous exchange | 9 | 1017 | 34 | 25220 | 3.47e-05 | 0.01 | 0.00 | 6.5 |
115 | | GO:0051591 | response to cAMP | 7 | 1019 | 18 | 25236 | 3.51e-05 | 0.01 | 0.00 | 9.6 |
116 | | GO:0007229 | integrin\-mediated signaling pathway | 13 | 1013 | 75 | 25179 | 3.61e-05 | 0.01 | 0.00 | 4.3 |
117 | | GO:0030308 | negative regulation of cell growth | 12 | 1014 | 64 | 25190 | 3.64e-05 | 0.01 | 0.00 | 4.6 |
118 | | GO:0006469 | negative regulation of protein kinase activity | 8 | 1018 | 26 | 25228 | 3.86e-05 | 0.01 | 0.00 | 7.6 |
119 | | GO:0001568 | blood vessel development | 9 | 1017 | 35 | 25219 | 4.21e-05 | 0.01 | 0.00 | 6.3 |
120 | | GO:0045429 | positive regulation of nitric oxide biosynthetic process | 6 | 1020 | 12 | 25242 | 4.33e-05 | 0.01 | 0.00 | 12.3 |
121 | | GO:0008643 | carbohydrate transport | 10 | 1016 | 45 | 25209 | 4.66e-05 | 0.01 | 0.00 | 5.5 |
122 | | GO:0051881 | regulation of mitochondrial membrane potential | 5 | 1021 | 7 | 25247 | 5.66e-05 | 0.00 | 0.00 | 17.6 |
123 | | GO:0008624 | induction of apoptosis by extracellular signals | 8 | 1018 | 28 | 25226 | 6.00e-05 | 0.01 | 0.00 | 7.0 |
124 | | GO:0051092 | activation of NF\-kappaB transcription factor | 8 | 1018 | 28 | 25226 | 6.00e-05 | 0.01 | 0.00 | 7.0 |
125 | | GO:0001934 | positive regulation of protein amino acid phosphorylation | 6 | 1020 | 13 | 25241 | 6.11e-05 | 0.01 | 0.00 | 11.4 |
126 | | GO:0051262 | protein tetramerization | 6 | 1020 | 13 | 25241 | 6.11e-05 | 0.01 | 0.00 | 11.4 |
127 | | GO:0043065 | positive regulation of apoptosis | 11 | 1015 | 58 | 25196 | 6.97e-05 | 0.01 | 0.00 | 4.7 |
128 | | GO:0001569 | patterning of blood vessels | 7 | 1019 | 21 | 25233 | 7.80e-05 | 0.01 | 0.00 | 8.2 |
129 | | GO:0050896 | response to stimulus | 8 | 1018 | 636 | 24618 | 7.93e-05 | 0.01 | 0.03 | 0.3 |
130 | | GO:0007160 | cell\-matrix adhesion | 14 | 1012 | 94 | 25160 | 8.04e-05 | 0.01 | 0.00 | 3.7 |
131 | | GO:0007517 | muscle development | 14 | 1012 | 94 | 25160 | 8.04e-05 | 0.01 | 0.00 | 3.7 |
132 | | GO:0045736 | negative regulation of cyclin\-dependent protein kinase activity | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
133 | | GO:0006559 | L\-phenylalanine catabolic process | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
134 | | GO:0055010 | ventricular cardiac muscle morphogenesis | 6 | 1020 | 14 | 25240 | 8.45e-05 | 0.01 | 0.00 | 10.5 |
135 | | GO:0048008 | platelet\-derived growth factor receptor signaling pathway | 5 | 1021 | 8 | 25246 | 8.90e-05 | 0.00 | 0.00 | 15.4 |
136 | | GO:0006464 | protein modification process | 25 | 1001 | 247 | 25007 | 9.05e-05 | 0.02 | 0.01 | 2.5 |
137 | | GO:0009636 | response to toxin | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
138 | | GO:0007040 | lysosome organization and biogenesis | 7 | 1019 | 22 | 25232 | 9.94e-05 | 0.01 | 0.00 | 7.8 |
139 | | GO:0009411 | response to UV | 8 | 1018 | 31 | 25223 | 1.10e-04 | 0.01 | 0.00 | 6.4 |
140 | | GO:0007399 | nervous system development | 34 | 992 | 391 | 24863 | 1.11e-04 | 0.03 | 0.02 | 2.1 |
141 | | GO:0016337 | cell\-cell adhesion | 13 | 1013 | 85 | 25169 | 1.13e-04 | 0.01 | 0.00 | 3.8 |
142 | | GO:0045840 | positive regulation of mitosis | 6 | 1020 | 15 | 25239 | 1.14e-04 | 0.01 | 0.00 | 9.8 |
143 | | GO:0009755 | hormone\-mediated signaling | 6 | 1020 | 15 | 25239 | 1.14e-04 | 0.01 | 0.00 | 9.8 |
144 | | GO:0045165 | cell fate commitment | 8 | 1018 | 32 | 25222 | 1.33e-04 | 0.01 | 0.00 | 6.2 |
145 | | GO:0000082 | G1/S transition of mitotic cell cycle | 10 | 1016 | 52 | 25202 | 1.34e-04 | 0.01 | 0.00 | 4.7 |
146 | | GO:0031663 | lipopolysaccharide\-mediated signaling pathway | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
147 | | GO:0043691 | reverse cholesterol transport | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
148 | | GO:0042100 | B cell proliferation | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
149 | | GO:0030225 | macrophage differentiation | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
150 | | GO:0030503 | regulation of cell redox homeostasis | 5 | 1021 | 9 | 25245 | 1.34e-04 | 0.00 | 0.00 | 13.7 |
151 | | GO:0007260 | tyrosine phosphorylation of STAT protein | 4 | 1022 | 4 | 25250 | 1.42e-04 | 0.00 | 0.00 | 24.6 |
152 | | GO:0007262 | STAT protein nuclear translocation | 4 | 1022 | 4 | 25250 | 1.42e-04 | 0.00 | 0.00 | 24.6 |
153 | | GO:0050679 | positive regulation of epithelial cell proliferation | 7 | 1019 | 24 | 25230 | 1.57e-04 | 0.01 | 0.00 | 7.2 |
154 | | GO:0007173 | epidermal growth factor receptor signaling pathway | 7 | 1019 | 24 | 25230 | 1.57e-04 | 0.01 | 0.00 | 7.2 |
155 | | GO:0007584 | response to nutrient | 11 | 1015 | 65 | 25189 | 1.71e-04 | 0.01 | 0.00 | 4.2 |
156 | | GO:0009725 | response to hormone stimulus | 7 | 1019 | 25 | 25229 | 1.94e-04 | 0.01 | 0.00 | 6.9 |
157 | | GO:0042088 | T\-helper 1 type immune response | 5 | 1021 | 10 | 25244 | 1.94e-04 | 0.00 | 0.00 | 12.3 |
158 | | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 5 | 1021 | 10 | 25244 | 1.94e-04 | 0.00 | 0.00 | 12.3 |
159 | | GO:0043542 | endothelial cell migration | 6 | 1020 | 17 | 25237 | 1.99e-04 | 0.01 | 0.00 | 8.7 |
160 | | GO:0016481 | negative regulation of transcription | 15 | 1011 | 117 | 25137 | 2.05e-04 | 0.01 | 0.00 | 3.2 |
161 | | GO:0000303 | response to superoxide | 4 | 1022 | 5 | 25249 | 2.49e-04 | 0.00 | 0.00 | 19.7 |
162 | | GO:0050798 | activated T cell proliferation | 4 | 1022 | 5 | 25249 | 2.49e-04 | 0.00 | 0.00 | 19.7 |
163 | | GO:0001755 | neural crest cell migration | 6 | 1020 | 18 | 25236 | 2.57e-04 | 0.01 | 0.00 | 8.2 |
164 | | GO:0042127 | regulation of cell proliferation | 10 | 1016 | 57 | 25197 | 2.59e-04 | 0.01 | 0.00 | 4.3 |
165 | | GO:0046716 | muscle maintenance | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
166 | | GO:0048009 | insulin\-like growth factor receptor signaling pathway | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
167 | | GO:0042446 | hormone biosynthetic process | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
168 | | GO:0006750 | glutathione biosynthetic process | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
169 | | GO:0045885 | positive regulation of survival gene product expression | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
170 | | GO:0019915 | sequestering of lipid | 5 | 1021 | 11 | 25243 | 2.74e-04 | 0.00 | 0.00 | 11.2 |
171 | | GO:0043434 | response to peptide hormone stimulus | 7 | 1019 | 27 | 25227 | 2.89e-04 | 0.01 | 0.00 | 6.4 |
172 | | GO:0007281 | germ cell development | 6 | 1020 | 19 | 25235 | 3.26e-04 | 0.01 | 0.00 | 7.8 |
173 | | GO:0006470 | protein amino acid dephosphorylation | 18 | 1008 | 166 | 25088 | 3.33e-04 | 0.02 | 0.01 | 2.7 |
174 | | GO:0042110 | T cell activation | 7 | 1019 | 28 | 25226 | 3.49e-04 | 0.01 | 0.00 | 6.2 |
175 | | GO:0046777 | protein amino acid autophosphorylation | 10 | 1016 | 60 | 25194 | 3.73e-04 | 0.01 | 0.00 | 4.1 |
176 | | GO:0042542 | response to hydrogen peroxide | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
177 | | GO:0050900 | leukocyte migration | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
178 | | GO:0007263 | nitric oxide mediated signal transduction | 5 | 1021 | 12 | 25242 | 3.75e-04 | 0.00 | 0.00 | 10.3 |
179 | | GO:0030900 | forebrain development | 9 | 1017 | 49 | 25205 | 3.88e-04 | 0.01 | 0.00 | 4.5 |
180 | | GO:0045123 | cellular extravasation | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
181 | | GO:0046902 | regulation of mitochondrial membrane permeability | 4 | 1022 | 6 | 25248 | 4.02e-04 | 0.00 | 0.00 | 16.4 |
182 | | GO:0006309 | DNA fragmentation during apoptosis | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
183 | | GO:0050731 | positive regulation of peptidyl\-tyrosine phosphorylation | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
184 | | GO:0042102 | positive regulation of T cell proliferation | 6 | 1020 | 20 | 25234 | 4.10e-04 | 0.01 | 0.00 | 7.4 |
185 | | GO:0005977 | glycogen metabolic process | 7 | 1019 | 29 | 25225 | 4.19e-04 | 0.01 | 0.00 | 5.9 |
186 | | GO:0042475 | odontogenesis of dentine\-containing teeth | 7 | 1019 | 29 | 25225 | 4.19e-04 | 0.01 | 0.00 | 5.9 |
187 | | GO:0006355 | regulation of transcription\, DNA\-dependent | 129 | 897 | 2319 | 22935 | 4.39e-04 | 0.13 | 0.09 | 1.4 |
188 | | GO:0007588 | excretion | 9 | 1017 | 50 | 25204 | 4.42e-04 | 0.01 | 0.00 | 4.4 |
189 | | GO:0019882 | antigen processing and presentation | 10 | 1016 | 62 | 25192 | 4.69e-04 | 0.01 | 0.00 | 4.0 |
190 | | GO:0030183 | B cell differentiation | 7 | 1019 | 30 | 25224 | 5.00e-04 | 0.01 | 0.00 | 5.7 |
191 | | GO:0007159 | leukocyte adhesion | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
192 | | GO:0050880 | regulation of blood vessel size | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
193 | | GO:0009072 | aromatic amino acid family metabolic process | 5 | 1021 | 13 | 25241 | 5.03e-04 | 0.00 | 0.00 | 9.5 |
194 | | GO:0006366 | transcription from RNA polymerase II promoter | 21 | 1005 | 219 | 25035 | 5.77e-04 | 0.02 | 0.01 | 2.4 |
195 | | GO:0050715 | positive regulation of cytokine secretion | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
196 | | GO:0045080 | positive regulation of chemokine biosynthetic process | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
197 | | GO:0008343 | adult feeding behavior | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
198 | | GO:0043496 | regulation of protein homodimerization activity | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
199 | | GO:0006983 | ER overload response | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
200 | | GO:0042136 | neurotransmitter biosynthetic process | 4 | 1022 | 7 | 25247 | 6.12e-04 | 0.00 | 0.00 | 14.1 |
201 | | GO:0016311 | dephosphorylation | 14 | 1012 | 117 | 25137 | 6.16e-04 | 0.01 | 0.00 | 2.9 |
202 | | GO:0007249 | I\-kappaB kinase/NF\-kappaB cascade | 6 | 1020 | 22 | 25232 | 6.28e-04 | 0.01 | 0.00 | 6.7 |
203 | | GO:0006357 | regulation of transcription from RNA polymerase II promoter | 21 | 1005 | 222 | 25032 | 6.59e-04 | 0.02 | 0.01 | 2.3 |
204 | | GO:0016575 | histone deacetylation | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
205 | | GO:0001502 | cartilage condensation | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
206 | | GO:0006833 | water transport | 5 | 1021 | 14 | 25240 | 6.61e-04 | 0.00 | 0.00 | 8.8 |
207 | | GO:0006974 | response to DNA damage stimulus | 8 | 1018 | 43 | 25211 | 7.52e-04 | 0.01 | 0.00 | 4.6 |
208 | | GO:0006641 | triacylglycerol metabolic process | 6 | 1020 | 23 | 25231 | 7.66e-04 | 0.01 | 0.00 | 6.4 |
209 | | GO:0007417 | central nervous system development | 13 | 1013 | 106 | 25148 | 7.74e-04 | 0.01 | 0.00 | 3.0 |
210 | | GO:0006260 | DNA replication | 16 | 1010 | 150 | 25104 | 8.19e-04 | 0.02 | 0.01 | 2.6 |
211 | | GO:0046330 | positive regulation of JNK cascade | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
212 | | GO:0050852 | T cell receptor signaling pathway | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
213 | | GO:0060048 | cardiac muscle contraction | 5 | 1021 | 15 | 25239 | 8.53e-04 | 0.00 | 0.00 | 8.2 |
214 | | GO:0030856 | regulation of epithelial cell differentiation | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
215 | | GO:0001782 | B cell homeostasis | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
216 | | GO:0045084 | positive regulation of interleukin\-12 biosynthetic process | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
217 | | GO:0006693 | prostaglandin metabolic process | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
218 | | GO:0050850 | positive regulation of calcium\-mediated signaling | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
219 | | GO:0042098 | T cell proliferation | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
220 | | GO:0045214 | sarcomere organization | 4 | 1022 | 8 | 25246 | 8.89e-04 | 0.00 | 0.00 | 12.3 |
221 | | GO:0008202 | steroid metabolic process | 10 | 1016 | 68 | 25186 | 8.93e-04 | 0.01 | 0.00 | 3.6 |
222 | | GO:0030336 | negative regulation of cell migration | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
223 | | GO:0000086 | G2/M transition of mitotic cell cycle | 6 | 1020 | 24 | 25230 | 9.27e-04 | 0.01 | 0.00 | 6.2 |
224 | | GO:0043627 | response to estrogen stimulus | 7 | 1019 | 34 | 25220 | 9.53e-04 | 0.01 | 0.00 | 5.1 |
225 | | GO:0030154 | cell differentiation | 35 | 991 | 465 | 24789 | 9.57e-04 | 0.03 | 0.02 | 1.9 |
226 | | GO:0030968 | unfolded protein response | 5 | 1021 | 16 | 25238 | 1.08e-03 | 0.00 | 0.00 | 7.7 |
227 | | GO:0001816 | cytokine production | 5 | 1021 | 16 | 25238 | 1.08e-03 | 0.00 | 0.00 | 7.7 |
228 | | GO:0002035 | brain renin\-angiotensin system | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
229 | | GO:0032100 | positive regulation of appetite | 3 | 1023 | 3 | 25251 | 1.09e-03 | 0.00 | 0.00 | 24.6 |
230 | | GO:0008637 | apoptotic mitochondrial changes | 4 | 1022 | 9 | 25245 | 1.25e-03 | 0.00 | 0.00 | 10.9 |
231 | | GO:0042326 | negative regulation of phosphorylation | 4 | 1022 | 9 | 25245 | 1.25e-03 | 0.00 | 0.00 | 10.9 |
232 | | GO:0050884 | neuromuscular process controlling posture | 4 | 1022 | 9 | 25245 | 1.25e-03 | 0.00 | 0.00 | 10.9 |
233 | | GO:0009952 | anterior/posterior pattern formation | 8 | 1018 | 47 | 25207 | 1.25e-03 | 0.01 | 0.00 | 4.2 |
234 | | GO:0007205 | activation of protein kinase C activity | 7 | 1019 | 36 | 25218 | 1.28e-03 | 0.01 | 0.00 | 4.8 |
235 | | GO:0007519 | skeletal muscle development | 7 | 1019 | 36 | 25218 | 1.28e-03 | 0.01 | 0.00 | 4.8 |
236 | | GO:0007243 | protein kinase cascade | 11 | 1015 | 85 | 25169 | 1.30e-03 | 0.01 | 0.00 | 3.2 |
237 | | GO:0030155 | regulation of cell adhesion | 6 | 1020 | 26 | 25228 | 1.32e-03 | 0.01 | 0.00 | 5.7 |
238 | | GO:0009749 | response to glucose stimulus | 5 | 1021 | 17 | 25237 | 1.36e-03 | 0.00 | 0.00 | 7.2 |
239 | | GO:0008543 | fibroblast growth factor receptor signaling pathway | 5 | 1021 | 17 | 25237 | 1.36e-03 | 0.00 | 0.00 | 7.2 |
240 | | GO:0042742 | defense response to bacterium | 12 | 1014 | 100 | 25154 | 1.44e-03 | 0.01 | 0.00 | 3.0 |
241 | | GO:0008544 | epidermis development | 12 | 1014 | 101 | 25153 | 1.55e-03 | 0.01 | 0.00 | 2.9 |
242 | | GO:0009615 | response to virus | 12 | 1014 | 102 | 25152 | 1.68e-03 | 0.01 | 0.00 | 2.9 |
243 | | GO:0045596 | negative regulation of cell differentiation | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
244 | | GO:0006626 | protein targeting to mitochondrion | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
245 | | GO:0006072 | glycerol\-3\-phosphate metabolic process | 5 | 1021 | 18 | 25236 | 1.68e-03 | 0.00 | 0.00 | 6.8 |
246 | | GO:0050729 | positive regulation of inflammatory response | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
247 | | GO:0045333 | cellular respiration | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
248 | | GO:0033344 | cholesterol efflux | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
249 | | GO:0006112 | energy reserve metabolic process | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
250 | | GO:0001516 | prostaglandin biosynthetic process | 4 | 1022 | 10 | 25244 | 1.69e-03 | 0.00 | 0.00 | 9.8 |
251 | | GO:0045893 | positive regulation of transcription\, DNA\-dependent | 12 | 1014 | 103 | 25151 | 1.81e-03 | 0.01 | 0.00 | 2.9 |
252 | | GO:0051216 | cartilage development | 6 | 1020 | 28 | 25226 | 1.84e-03 | 0.01 | 0.00 | 5.3 |
253 | | GO:0019430 | removal of superoxide radicals | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
254 | | GO:0045723 | positive regulation of fatty acid biosynthetic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
255 | | GO:0002740 | negative regulation of cytokine secretion during immune response | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
256 | | GO:0046887 | positive regulation of hormone secretion | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
257 | | GO:0032488 | Cdc42 protein signal transduction | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
258 | | GO:0021940 | positive regulation of granule cell precursor proliferation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
259 | | GO:0042167 | heme catabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
260 | | GO:0042092 | T\-helper 2 type immune response | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
261 | | GO:0001955 | blood vessel maturation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
262 | | GO:0001659 | temperature homeostasis | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
263 | | GO:0032024 | positive regulation of insulin secretion | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
264 | | GO:0006101 | citrate metabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
265 | | GO:0032909 | regulation of transforming growth factor\-beta2 production | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
266 | | GO:0007167 | enzyme linked receptor protein signaling pathway | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
267 | | GO:0051900 | regulation of mitochondrial depolarization | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
268 | | GO:0043011 | myeloid dendritic cell differentiation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
269 | | GO:0045579 | positive regulation of B cell differentiation | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
270 | | GO:0051209 | release of sequestered calcium ion into cytosol | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
271 | | GO:0051898 | negative regulation of protein kinase B signaling cascade | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
272 | | GO:0021915 | neural tube development | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
273 | | GO:0045415 | negative regulation of interleukin\-8 biosynthetic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
274 | | GO:0046697 | decidualization | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
275 | | GO:0006104 | succinyl\-CoA metabolic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
276 | | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 3 | 1023 | 4 | 25250 | 1.85e-03 | 0.00 | 0.00 | 18.5 |
277 | | GO:0007204 | elevation of cytosolic calcium ion concentration | 10 | 1016 | 76 | 25178 | 1.90e-03 | 0.01 | 0.00 | 3.2 |
278 | | GO:0001822 | kidney development | 5 | 1021 | 19 | 25235 | 2.05e-03 | 0.00 | 0.00 | 6.5 |
279 | | GO:0009612 | response to mechanical stimulus | 5 | 1021 | 19 | 25235 | 2.05e-03 | 0.00 | 0.00 | 6.5 |
280 | | GO:0006284 | base\-excision repair | 6 | 1020 | 29 | 25225 | 2.15e-03 | 0.01 | 0.00 | 5.1 |
281 | | GO:0001843 | neural tube closure | 6 | 1020 | 29 | 25225 | 2.15e-03 | 0.01 | 0.00 | 5.1 |
282 | | GO:0008652 | amino acid biosynthetic process | 6 | 1020 | 29 | 25225 | 2.15e-03 | 0.01 | 0.00 | 5.1 |
283 | | GO:0007179 | transforming growth factor beta receptor signaling pathway | 7 | 1019 | 40 | 25214 | 2.18e-03 | 0.01 | 0.00 | 4.3 |
284 | | GO:0050930 | induction of positive chemotaxis | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
285 | | GO:0030890 | positive regulation of B cell proliferation | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
286 | | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
287 | | GO:0050870 | positive regulation of T cell activation | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
288 | | GO:0045843 | negative regulation of striated muscle development | 4 | 1022 | 11 | 25243 | 2.23e-03 | 0.00 | 0.00 | 9.0 |
289 | | GO:0040007 | growth | 6 | 1020 | 30 | 25224 | 2.49e-03 | 0.01 | 0.00 | 4.9 |
290 | | GO:0030334 | regulation of cell migration | 6 | 1020 | 30 | 25224 | 2.49e-03 | 0.01 | 0.00 | 4.9 |
291 | | GO:0042346 | positive regulation of NF\-kappaB import into nucleus | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
292 | | GO:0045079 | negative regulation of chemokine biosynthetic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
293 | | GO:0000302 | response to reactive oxygen species | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
294 | | GO:0043497 | regulation of protein heterodimerization activity | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
295 | | GO:0048147 | negative regulation of fibroblast proliferation | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
296 | | GO:0001678 | cellular glucose homeostasis | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
297 | | GO:0019932 | second\-messenger\-mediated signaling | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
298 | | GO:0006534 | cysteine metabolic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
299 | | GO:0008053 | mitochondrial fusion | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
300 | | GO:0045213 | neurotransmitter receptor metabolic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
301 | | GO:0044255 | cellular lipid metabolic process | 3 | 1023 | 5 | 25249 | 2.87e-03 | 0.00 | 0.00 | 14.8 |
302 | | GO:0019229 | regulation of vasoconstriction | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
303 | | GO:0042730 | fibrinolysis | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
304 | | GO:0045765 | regulation of angiogenesis | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
305 | | GO:0030041 | actin filament polymerization | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
306 | | GO:0048146 | positive regulation of fibroblast proliferation | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
307 | | GO:0030217 | T cell differentiation | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
308 | | GO:0048066 | pigmentation during development | 4 | 1022 | 12 | 25242 | 2.88e-03 | 0.00 | 0.00 | 8.2 |
309 | | GO:0008016 | regulation of heart contraction | 7 | 1019 | 43 | 25211 | 3.12e-03 | 0.01 | 0.00 | 4.0 |
310 | | GO:0006944 | membrane fusion | 5 | 1021 | 22 | 25232 | 3.54e-03 | 0.00 | 0.00 | 5.6 |
311 | | GO:0007569 | cell aging | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
312 | | GO:0050680 | negative regulation of epithelial cell proliferation | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
313 | | GO:0019233 | sensory perception of pain | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
314 | | GO:0008037 | cell recognition | 4 | 1022 | 13 | 25241 | 3.66e-03 | 0.00 | 0.00 | 7.6 |
315 | | GO:0000079 | regulation of cyclin\-dependent protein kinase activity | 7 | 1019 | 45 | 25209 | 3.91e-03 | 0.01 | 0.00 | 3.8 |
316 | | GO:0046688 | response to copper ion | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
317 | | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
318 | | GO:0007406 | negative regulation of neuroblast proliferation | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
319 | | GO:0051101 | regulation of DNA binding | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
320 | | GO:0043029 | T cell homeostasis | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
321 | | GO:0007259 | JAK\-STAT cascade | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
322 | | GO:0045348 | positive regulation of MHC class II biosynthetic process | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
323 | | GO:0048304 | positive regulation of isotype switching to IgG isotypes | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
324 | | GO:0043552 | positive regulation of phosphoinositide 3\-kinase activity | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
325 | | GO:0043392 | negative regulation of DNA binding | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
326 | | GO:0007005 | mitochondrion organization and biogenesis | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
327 | | GO:0042594 | response to starvation | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
328 | | GO:0030335 | positive regulation of cell migration | 5 | 1021 | 23 | 25231 | 4.18e-03 | 0.00 | 0.00 | 5.4 |
329 | | GO:0002027 | regulation of heart rate | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
330 | | GO:0051098 | regulation of binding | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
331 | | GO:0007500 | mesodermal cell fate determination | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
332 | | GO:0051271 | negative regulation of cell motility | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
333 | | GO:0042551 | neuron maturation | 3 | 1023 | 6 | 25248 | 4.18e-03 | 0.00 | 0.00 | 12.3 |
334 | | GO:0045454 | cell redox homeostasis | 7 | 1019 | 46 | 25208 | 4.36e-03 | 0.01 | 0.00 | 3.7 |
335 | | GO:0016049 | cell growth | 7 | 1019 | 46 | 25208 | 4.36e-03 | 0.01 | 0.00 | 3.7 |
336 | | GO:0007568 | aging | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
337 | | GO:0042592 | homeostatic process | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
338 | | GO:0045860 | positive regulation of protein kinase activity | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
339 | | GO:0007250 | activation of NF\-kappaB\-inducing kinase activity | 4 | 1022 | 14 | 25240 | 4.56e-03 | 0.00 | 0.00 | 7.0 |
340 | | GO:0001570 | vasculogenesis | 6 | 1020 | 35 | 25219 | 4.88e-03 | 0.01 | 0.00 | 4.2 |
341 | | GO:0006817 | phosphate transport | 11 | 1015 | 104 | 25150 | 5.38e-03 | 0.01 | 0.00 | 2.6 |
342 | | GO:0045471 | response to ethanol | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
343 | | GO:0042311 | vasodilation | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
344 | | GO:0050776 | regulation of immune response | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
345 | | GO:0048754 | branching morphogenesis of a tube | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
346 | | GO:0016043 | cellular component organization and biogenesis | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
347 | | GO:0001657 | ureteric bud development | 4 | 1022 | 15 | 25239 | 5.60e-03 | 0.00 | 0.00 | 6.6 |
348 | | GO:0016358 | dendrite development | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
349 | | GO:0007257 | activation of JNK activity | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
350 | | GO:0007422 | peripheral nervous system development | 5 | 1021 | 25 | 25229 | 5.68e-03 | 0.00 | 0.00 | 4.9 |
351 | | GO:0043330 | response to exogenous dsRNA | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
352 | | GO:0048255 | mRNA stabilization | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
353 | | GO:0045410 | positive regulation of interleukin\-6 biosynthetic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
354 | | GO:0050727 | regulation of inflammatory response | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
355 | | GO:0030838 | positive regulation of actin filament polymerization | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
356 | | GO:0006546 | glycine catabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
357 | | GO:0042133 | neurotransmitter metabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
358 | | GO:0006084 | acetyl\-CoA metabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
359 | | GO:0006536 | glutamate metabolic process | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
360 | | GO:0030193 | regulation of blood coagulation | 3 | 1023 | 7 | 25247 | 5.79e-03 | 0.00 | 0.00 | 10.5 |
361 | | GO:0001701 | in utero embryonic development | 8 | 1018 | 63 | 25191 | 6.35e-03 | 0.01 | 0.00 | 3.1 |
362 | | GO:0045892 | negative regulation of transcription\, DNA\-dependent | 9 | 1017 | 77 | 25177 | 6.36e-03 | 0.01 | 0.00 | 2.9 |
363 | | GO:0006268 | DNA unwinding during replication | 5 | 1021 | 26 | 25228 | 6.56e-03 | 0.00 | 0.00 | 4.7 |
364 | | GO:0050885 | neuromuscular process controlling balance | 5 | 1021 | 26 | 25228 | 6.56e-03 | 0.00 | 0.00 | 4.7 |
365 | | GO:0006281 | DNA repair | 18 | 1008 | 220 | 25034 | 6.72e-03 | 0.02 | 0.01 | 2.0 |
366 | | GO:0009408 | response to heat | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
367 | | GO:0001759 | induction of an organ | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
368 | | GO:0007215 | glutamate signaling pathway | 4 | 1022 | 16 | 25238 | 6.79e-03 | 0.00 | 0.00 | 6.2 |
369 | | GO:0040014 | regulation of multicellular organism growth | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
370 | | GO:0001542 | ovulation from ovarian follicle | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
371 | | GO:0045776 | negative regulation of blood pressure | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
372 | | GO:0046888 | negative regulation of hormone secretion | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
373 | | GO:0045671 | negative regulation of osteoclast differentiation | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
374 | | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
375 | | GO:0006583 | melanin biosynthetic process from tyrosine | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
376 | | GO:0045416 | positive regulation of interleukin\-8 biosynthetic process | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
377 | | GO:0048738 | cardiac muscle development | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
378 | | GO:0017156 | calcium ion\-dependent exocytosis | 3 | 1023 | 8 | 25246 | 7.74e-03 | 0.00 | 0.00 | 9.2 |
379 | | GO:0009653 | anatomical structure morphogenesis | 13 | 1013 | 133 | 25121 | 7.76e-03 | 0.01 | 0.01 | 2.4 |
380 | | GO:0008629 | induction of apoptosis by intracellular signals | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
381 | | GO:0015671 | oxygen transport | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
382 | | GO:0006800 | oxygen and reactive oxygen species metabolic process | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
383 | | GO:0045766 | positive regulation of angiogenesis | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
384 | | GO:0006171 | cAMP biosynthetic process | 4 | 1022 | 17 | 25237 | 8.13e-03 | 0.00 | 0.00 | 5.8 |
385 | | GO:0006959 | humoral immune response | 6 | 1020 | 40 | 25214 | 8.62e-03 | 0.01 | 0.00 | 3.7 |
386 | | GO:0030097 | hemopoiesis | 6 | 1020 | 40 | 25214 | 8.62e-03 | 0.01 | 0.00 | 3.7 |
387 | | GO:0031667 | response to nutrient levels | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
388 | | GO:0045541 | negative regulation of cholesterol biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
389 | | GO:0048678 | response to axon injury | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
390 | | GO:0032800 | receptor biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
391 | | GO:0019049 | evasion of host defenses by virus | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
392 | | GO:0006739 | NADP metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
393 | | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
394 | | GO:0045721 | negative regulation of gluconeogenesis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
395 | | GO:0045923 | positive regulation of fatty acid metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
396 | | GO:0006788 | heme oxidation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
397 | | GO:0031670 | cellular response to nutrient | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
398 | | GO:0031668 | cellular response to extracellular stimulus | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
399 | | GO:0045191 | regulation of isotype switching | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
400 | | GO:0019438 | aromatic compound biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
401 | | GO:0046013 | regulation of T cell homeostatic proliferation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
402 | | GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
403 | | GO:0030851 | granulocyte differentiation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
404 | | GO:0048568 | embryonic organ development | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
405 | | GO:0001779 | natural killer cell differentiation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
406 | | GO:0019218 | regulation of steroid metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
407 | | GO:0046543 | development of secondary female sexual characteristics | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
408 | | GO:0046544 | development of secondary male sexual characteristics | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
409 | | GO:0021978 | telencephalon regionalization | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
410 | | GO:0010248 | establishment and/or maintenance of transmembrane electrochemical gradient | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
411 | | GO:0009743 | response to carbohydrate stimulus | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
412 | | GO:0046666 | retinal cell programmed cell death | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
413 | | GO:0031998 | regulation of fatty acid beta\-oxidation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
414 | | GO:0046855 | inositol phosphate dephosphorylation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
415 | | GO:0046856 | phosphoinositide dephosphorylation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
416 | | GO:0046621 | negative regulation of organ growth | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
417 | | GO:0006106 | fumarate metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
418 | | GO:0048873 | homeostasis of number of cells within a tissue | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
419 | | GO:0050922 | negative regulation of chemotaxis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
420 | | GO:0043547 | positive regulation of GTPase activity | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
421 | | GO:0045646 | regulation of erythrocyte differentiation | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
422 | | GO:0007497 | posterior midgut development | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
423 | | GO:0030819 | positive regulation of cAMP biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
424 | | GO:0046950 | ketone body metabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
425 | | GO:0006982 | response to lipid hydroperoxide | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
426 | | GO:0043653 | mitochondrial fragmentation during apoptosis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
427 | | GO:0019510 | S\-adenosylhomocysteine catabolic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
428 | | GO:0035229 | positive regulation of glutamate\-cysteine ligase activity | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
429 | | GO:0051409 | response to nitrosative stress | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
430 | | GO:0006701 | progesterone biosynthetic process | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
431 | | GO:0043587 | tongue morphogenesis | 2 | 1024 | 2 | 25252 | 8.67e-03 | 0.00 | 0.00 | 24.6 |
432 | | GO:0008104 | protein localization | 6 | 1020 | 41 | 25213 | 9.56e-03 | 0.01 | 0.00 | 3.6 |
433 | | GO:0006306 | DNA methylation | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
434 | | GO:0008630 | DNA damage response\, signal transduction resulting in induction of apoptosis | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
435 | | GO:0006541 | glutamine metabolic process | 4 | 1022 | 18 | 25236 | 9.63e-03 | 0.00 | 0.00 | 5.5 |
436 | | GO:0046325 | negative regulation of glucose import | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
437 | | GO:0045930 | negative regulation of mitotic cell cycle | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
438 | | GO:0030301 | cholesterol transport | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
439 | | GO:0030049 | muscle filament sliding | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
440 | | GO:0045987 | positive regulation of smooth muscle contraction | 3 | 1023 | 9 | 25245 | 1.00e-02 | 0.00 | 0.00 | 8.2 |
441 | | GO:0001764 | neuron migration | 8 | 1018 | 69 | 25185 | 1.03e-02 | 0.01 | 0.00 | 2.9 |
442 | | GO:0008219 | cell death | 7 | 1019 | 55 | 25199 | 1.03e-02 | 0.01 | 0.00 | 3.1 |
443 | | GO:0015986 | ATP synthesis coupled proton transport | 7 | 1019 | 55 | 25199 | 1.03e-02 | 0.01 | 0.00 | 3.1 |
444 | | GO:0030521 | androgen receptor signaling pathway | 6 | 1020 | 42 | 25212 | 1.06e-02 | 0.01 | 0.00 | 3.5 |
445 | | GO:0051301 | cell division | 18 | 1008 | 224 | 25030 | 1.08e-02 | 0.02 | 0.01 | 2.0 |
446 | | GO:0007610 | behavior | 5 | 1021 | 30 | 25224 | 1.10e-02 | 0.00 | 0.00 | 4.1 |
447 | | GO:0051260 | protein homooligomerization | 8 | 1018 | 70 | 25184 | 1.10e-02 | 0.01 | 0.00 | 2.8 |
448 | | GO:0043433 | negative regulation of transcription factor activity | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
449 | | GO:0001649 | osteoblast differentiation | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
450 | | GO:0007194 | negative regulation of adenylate cyclase activity | 4 | 1022 | 19 | 25235 | 1.13e-02 | 0.00 | 0.00 | 5.2 |
451 | | GO:0030238 | male sex determination | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
452 | | GO:0042755 | eating behavior | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
453 | | GO:0042771 | DNA damage response\, signal transduction by p53 class mediator resulting in induction of apoptosis | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
454 | | GO:0006098 | pentose\-phosphate shunt | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
455 | | GO:0007213 | acetylcholine receptor signaling\, muscarinic pathway | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
456 | | GO:0005980 | glycogen catabolic process | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
457 | | GO:0045445 | myoblast differentiation | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
458 | | GO:0007043 | cell\-cell junction assembly | 3 | 1023 | 10 | 25244 | 1.26e-02 | 0.00 | 0.00 | 7.4 |
459 | | GO:0016567 | protein ubiquitination | 8 | 1018 | 72 | 25182 | 1.28e-02 | 0.01 | 0.00 | 2.7 |
460 | | GO:0006302 | double\-strand break repair | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
461 | | GO:0043473 | pigmentation | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
462 | | GO:0050821 | protein stabilization | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
463 | | GO:0007189 | G\-protein signaling\, adenylate cyclase activating pathway | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
464 | | GO:0030879 | mammary gland development | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
465 | | GO:0006164 | purine nucleotide biosynthetic process | 4 | 1022 | 20 | 25234 | 1.32e-02 | 0.00 | 0.00 | 4.9 |
466 | | GO:0051000 | positive regulation of nitric\-oxide synthase activity | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
467 | | GO:0050665 | hydrogen peroxide biosynthetic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
468 | | GO:0060047 | heart contraction | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
469 | | GO:0001933 | negative regulation of protein amino acid phosphorylation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
470 | | GO:0051023 | regulation of immunoglobulin secretion | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
471 | | GO:0045071 | negative regulation of viral genome replication | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
472 | | GO:0030185 | nitric oxide transport | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
473 | | GO:0031960 | response to corticosteroid stimulus | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
474 | | GO:0006924 | activated T cell apoptosis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
475 | | GO:0002003 | angiotensin maturation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
476 | | GO:0030264 | nuclear fragmentation during apoptosis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
477 | | GO:0030072 | peptide hormone secretion | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
478 | | GO:0019217 | regulation of fatty acid metabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
479 | | GO:0042119 | neutrophil activation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
480 | | GO:0045722 | positive regulation of gluconeogenesis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
481 | | GO:0051156 | glucose 6\-phosphate metabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
482 | | GO:0030240 | muscle thin filament assembly | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
483 | | GO:0042335 | cuticle development | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
484 | | GO:0046668 | regulation of retinal cell programmed cell death | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
485 | | GO:0030644 | cellular chloride ion homeostasis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
486 | | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
487 | | GO:0006102 | isocitrate metabolic process | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
488 | | GO:0033700 | phospholipid efflux | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
489 | | GO:0060037 | pharyngeal system development | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
490 | | GO:0001954 | positive regulation of cell\-matrix adhesion | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
491 | | GO:0045672 | positive regulation of osteoclast differentiation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
492 | | GO:0006540 | glutamate decarboxylation to succinate | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
493 | | GO:0001553 | luteinization | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
494 | | GO:0048562 | embryonic organ morphogenesis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
495 | | GO:0006496 | protein amino acid terminal N\-glycosylation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
496 | | GO:0008582 | regulation of synaptic growth at neuromuscular junction | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
497 | | GO:0006287 | base\-excision repair\, gap\-filling | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
498 | | GO:0050891 | multicellular organismal water homeostasis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
499 | | GO:0006975 | DNA damage induced protein phosphorylation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
500 | | GO:0007435 | salivary gland morphogenesis | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
501 | | GO:0002268 | follicular dendritic cell differentiation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
502 | | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 2 | 1024 | 3 | 25251 | 1.41e-02 | 0.00 | 0.00 | 16.4 |
503 | | GO:0019370 | leukotriene biosynthetic process | 4 | 1022 | 21 | 25233 | 1.52e-02 | 0.00 | 0.00 | 4.7 |
504 | | GO:0007254 | JNK cascade | 5 | 1021 | 33 | 25221 | 1.55e-02 | 0.00 | 0.00 | 3.7 |
505 | | GO:0051402 | neuron apoptosis | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
506 | | GO:0045597 | positive regulation of cell differentiation | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
507 | | GO:0030901 | midbrain development | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
508 | | GO:0045086 | positive regulation of interleukin\-2 biosynthetic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
509 | | GO:0051289 | protein homotetramerization | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
510 | | GO:0006527 | arginine catabolic process | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
511 | | GO:0031116 | positive regulation of microtubule polymerization | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
512 | | GO:0000080 | G1 phase of mitotic cell cycle | 3 | 1023 | 11 | 25243 | 1.56e-02 | 0.00 | 0.00 | 6.7 |
513 | | GO:0006730 | one\-carbon compound metabolic process | 6 | 1020 | 47 | 25207 | 1.68e-02 | 0.01 | 0.00 | 3.1 |
514 | | GO:0007200 | G\-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | 5 | 1021 | 34 | 25220 | 1.72e-02 | 0.00 | 0.00 | 3.6 |
515 | | GO:0006805 | xenobiotic metabolic process | 5 | 1021 | 34 | 25220 | 1.72e-02 | 0.00 | 0.00 | 3.6 |
516 | | GO:0007586 | digestion | 8 | 1018 | 77 | 25177 | 1.79e-02 | 0.01 | 0.00 | 2.6 |
517 | | GO:0006878 | cellular copper ion homeostasis | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
518 | | GO:0042130 | negative regulation of T cell proliferation | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
519 | | GO:0006691 | leukotriene metabolic process | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
520 | | GO:0042733 | embryonic digit morphogenesis | 3 | 1023 | 12 | 25242 | 1.90e-02 | 0.00 | 0.00 | 6.2 |
521 | | GO:0006826 | iron ion transport | 5 | 1021 | 35 | 25219 | 1.91e-02 | 0.00 | 0.00 | 3.5 |
522 | | GO:0001890 | placenta development | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
523 | | GO:0009190 | cyclic nucleotide biosynthetic process | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
524 | | GO:0042157 | lipoprotein metabolic process | 4 | 1022 | 23 | 25231 | 1.98e-02 | 0.00 | 0.00 | 4.3 |
525 | | GO:0060087 | relaxation of vascular smooth muscle | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
526 | | GO:0030432 | peristalsis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
527 | | GO:0045670 | regulation of osteoclast differentiation | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
528 | | GO:0050901 | leukocyte tethering or rolling | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
529 | | GO:0006927 | transformed cell apoptosis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
530 | | GO:0043267 | negative regulation of potassium ion transport | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
531 | | GO:0001781 | neutrophil apoptosis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
532 | | GO:0045741 | positive regulation of epidermal growth factor receptor activity | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
533 | | GO:0014065 | phosphoinositide 3\-kinase cascade | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
534 | | GO:0001660 | fever | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
535 | | GO:0046326 | positive regulation of glucose import | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
536 | | GO:0010039 | response to iron ion | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
537 | | GO:0031000 | response to caffeine | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
538 | | GO:0015760 | glucose\-6\-phosphate transport | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
539 | | GO:0006390 | transcription from mitochondrial promoter | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
540 | | GO:0008628 | induction of apoptosis by hormones | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
541 | | GO:0009410 | response to xenobiotic stimulus | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
542 | | GO:0048771 | tissue remodeling | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
543 | | GO:0006980 | redox signal response | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
544 | | GO:0007518 | myoblast cell fate determination | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
545 | | GO:0010468 | regulation of gene expression | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
546 | | GO:0018076 | N\-terminal peptidyl\-lysine acetylation | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
547 | | GO:0001667 | ameboidal cell migration | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
548 | | GO:0051895 | negative regulation of focal adhesion formation | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
549 | | GO:0031623 | receptor internalization | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
550 | | GO:0007009 | plasma membrane organization and biogenesis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
551 | | GO:0030431 | sleep | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
552 | | GO:0001919 | regulation of receptor recycling | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
553 | | GO:0045409 | negative regulation of interleukin\-6 biosynthetic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
554 | | GO:0007183 | SMAD protein complex assembly | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
555 | | GO:0006533 | aspartate catabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
556 | | GO:0055091 | phospholipid homeostasis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
557 | | GO:0046470 | phosphatidylcholine metabolic process | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
558 | | GO:0007442 | hindgut morphogenesis | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
559 | | GO:0006312 | mitotic recombination | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
560 | | GO:0002467 | germinal center formation | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
561 | | GO:0042345 | regulation of NF\-kappaB import into nucleus | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
562 | | GO:0000154 | rRNA modification | 2 | 1024 | 4 | 25250 | 2.06e-02 | 0.00 | 0.00 | 12.3 |
563 | | GO:0009239 | enterobactin biosynthetic process | 5 | 1021 | 36 | 25218 | 2.10e-02 | 0.00 | 0.00 | 3.4 |
564 | | GO:0030168 | platelet activation | 4 | 1022 | 24 | 25230 | 2.24e-02 | 0.00 | 0.00 | 4.1 |
565 | | GO:0002026 | regulation of the force of heart contraction | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
566 | | GO:0006937 | regulation of muscle contraction | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
567 | | GO:0043525 | positive regulation of neuron apoptosis | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
568 | | GO:0007567 | parturition | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
569 | | GO:0045785 | positive regulation of cell adhesion | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
570 | | GO:0000050 | urea cycle | 3 | 1023 | 13 | 25241 | 2.27e-02 | 0.00 | 0.00 | 5.7 |
571 | | GO:0000226 | microtubule cytoskeleton organization and biogenesis | 5 | 1021 | 37 | 25217 | 2.31e-02 | 0.00 | 0.00 | 3.3 |
572 | | GO:0007626 | locomotory behavior | 6 | 1020 | 51 | 25203 | 2.33e-02 | 0.01 | 0.00 | 2.9 |
573 | | GO:0006695 | cholesterol biosynthetic process | 4 | 1022 | 25 | 25229 | 2.52e-02 | 0.00 | 0.00 | 3.9 |
574 | | GO:0046854 | phosphoinositide phosphorylation | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
575 | | GO:0001837 | epithelial to mesenchymal transition | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
576 | | GO:0051607 | defense response to virus | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
577 | | GO:0030032 | lamellipodium biogenesis | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
578 | | GO:0000186 | activation of MAPKK activity | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
579 | | GO:0001707 | mesoderm formation | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
580 | | GO:0030509 | BMP signaling pathway | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
581 | | GO:0008154 | actin polymerization and/or depolymerization | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
582 | | GO:0001656 | metanephros development | 3 | 1023 | 14 | 25240 | 2.68e-02 | 0.00 | 0.00 | 5.3 |
583 | | GO:0006869 | lipid transport | 7 | 1019 | 68 | 25186 | 2.70e-02 | 0.01 | 0.00 | 2.5 |
584 | | GO:0001895 | retina homeostasis | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
585 | | GO:0046627 | negative regulation of insulin receptor signaling pathway | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
586 | | GO:0010035 | response to inorganic substance | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
587 | | GO:0045822 | negative regulation of heart contraction | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
588 | | GO:0042832 | defense response to protozoan | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
589 | | GO:0030889 | negative regulation of B cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
590 | | GO:0030818 | negative regulation of cAMP biosynthetic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
591 | | GO:0042158 | lipoprotein biosynthetic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
592 | | GO:0045600 | positive regulation of fat cell differentiation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
593 | | GO:0006972 | hyperosmotic response | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
594 | | GO:0002237 | response to molecule of bacterial origin | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
595 | | GO:0007253 | cytoplasmic sequestering of NF\-kappaB | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
596 | | GO:0046835 | carbohydrate phosphorylation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
597 | | GO:0051707 | response to other organism | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
598 | | GO:0006689 | ganglioside catabolic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
599 | | GO:0048340 | paraxial mesoderm morphogenesis | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
600 | | GO:0045647 | negative regulation of erythrocyte differentiation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
601 | | GO:0008088 | axon cargo transport | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
602 | | GO:0006110 | regulation of glycolysis | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
603 | | GO:0051353 | positive regulation of oxidoreductase activity | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
604 | | GO:0040023 | establishment of nucleus localization | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
605 | | GO:0002062 | chondrocyte differentiation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
606 | | GO:0045162 | clustering of voltage\-gated sodium channels | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
607 | | GO:0042310 | vasoconstriction | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
608 | | GO:0014047 | glutamate secretion | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
609 | | GO:0032691 | negative regulation of interleukin\-1 beta production | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
610 | | GO:0030502 | negative regulation of bone mineralization | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
611 | | GO:0007006 | mitochondrial membrane organization and biogenesis | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
612 | | GO:0021513 | spinal cord dorsal/ventral patterning | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
613 | | GO:0051001 | negative regulation of nitric\-oxide synthase activity | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
614 | | GO:0002053 | positive regulation of mesenchymal cell proliferation | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
615 | | GO:0006563 | L\-serine metabolic process | 2 | 1024 | 5 | 25249 | 2.81e-02 | 0.00 | 0.00 | 9.8 |
616 | | GO:0042552 | myelination | 4 | 1022 | 26 | 25228 | 2.82e-02 | 0.00 | 0.00 | 3.8 |
617 | | GO:0016042 | lipid catabolic process | 10 | 1016 | 112 | 25142 | 2.90e-02 | 0.01 | 0.00 | 2.2 |
618 | | GO:0050826 | response to freezing | 15 | 1011 | 196 | 25058 | 2.91e-02 | 0.01 | 0.01 | 1.9 |
619 | | GO:0042309 | homoiothermy | 15 | 1011 | 197 | 25057 | 2.95e-02 | 0.01 | 0.01 | 1.9 |
620 | | GO:0001974 | blood vessel remodeling | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
621 | | GO:0043410 | positive regulation of MAPKKK cascade | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
622 | | GO:0030099 | myeloid cell differentiation | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
623 | | GO:0019752 | carboxylic acid metabolic process | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
624 | | GO:0006637 | acyl\-CoA metabolic process | 3 | 1023 | 15 | 25239 | 3.12e-02 | 0.00 | 0.00 | 4.9 |
625 | | GO:0016310 | phosphorylation | 4 | 1022 | 27 | 25227 | 3.14e-02 | 0.00 | 0.00 | 3.6 |
626 | | GO:0007498 | mesoderm development | 4 | 1022 | 28 | 25226 | 3.49e-02 | 0.00 | 0.00 | 3.5 |
627 | | GO:0001937 | negative regulation of endothelial cell proliferation | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
628 | | GO:0030203 | glycosaminoglycan metabolic process | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
629 | | GO:0030218 | erythrocyte differentiation | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
630 | | GO:0030318 | melanocyte differentiation | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
631 | | GO:0030282 | bone mineralization | 3 | 1023 | 16 | 25238 | 3.60e-02 | 0.00 | 0.00 | 4.6 |
632 | | GO:0045909 | positive regulation of vasodilation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
633 | | GO:0051145 | smooth muscle cell differentiation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
634 | | GO:0032715 | negative regulation of interleukin\-6 production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
635 | | GO:0051346 | negative regulation of hydrolase activity | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
636 | | GO:0048662 | negative regulation of smooth muscle cell proliferation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
637 | | GO:0008210 | estrogen metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
638 | | GO:0045779 | negative regulation of bone resorption | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
639 | | GO:0016202 | regulation of striated muscle development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
640 | | GO:0050777 | negative regulation of immune response | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
641 | | GO:0031575 | G1/S transition checkpoint | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
642 | | GO:0051091 | positive regulation of transcription factor activity | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
643 | | GO:0030031 | cell projection biogenesis | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
644 | | GO:0030166 | proteoglycan biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
645 | | GO:0006636 | unsaturated fatty acid biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
646 | | GO:0042327 | positive regulation of phosphorylation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
647 | | GO:0006544 | glycine metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
648 | | GO:0008634 | negative regulation of survival gene product expression | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
649 | | GO:0035264 | multicellular organism growth | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
650 | | GO:0001953 | negative regulation of cell\-matrix adhesion | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
651 | | GO:0045773 | positive regulation of axon extension | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
652 | | GO:0016081 | synaptic vesicle docking during exocytosis | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
653 | | GO:0006002 | fructose 6\-phosphate metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
654 | | GO:0043249 | erythrocyte maturation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
655 | | GO:0050673 | epithelial cell proliferation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
656 | | GO:0006108 | malate metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
657 | | GO:0006085 | acetyl\-CoA biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
658 | | GO:0008209 | androgen metabolic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
659 | | GO:0031647 | regulation of protein stability | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
660 | | GO:0001958 | endochondral ossification | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
661 | | GO:0006526 | arginine biosynthetic process | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
662 | | GO:0032729 | positive regulation of interferon\-gamma production | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
663 | | GO:0002076 | osteoblast development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
664 | | GO:0045666 | positive regulation of neuron differentiation | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
665 | | GO:0032869 | cellular response to insulin stimulus | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
666 | | GO:0045907 | positive regulation of vasoconstriction | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
667 | | GO:0030850 | prostate gland development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
668 | | GO:0048589 | developmental growth | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
669 | | GO:0009266 | response to temperature stimulus | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
670 | | GO:0048536 | spleen development | 2 | 1024 | 6 | 25248 | 3.65e-02 | 0.00 | 0.00 | 8.2 |
671 | | GO:0006334 | nucleosome assembly | 2 | 1024 | 185 | 25069 | 3.67e-02 | 0.00 | 0.01 | 0.3 |
672 | | GO:0007186 | G\-protein coupled receptor protein signaling pathway | 68 | 958 | 1296 | 23958 | 3.73e-02 | 0.07 | 0.05 | 1.3 |
673 | | GO:0000165 | MAPKKK cascade | 4 | 1022 | 29 | 25225 | 3.85e-02 | 0.00 | 0.00 | 3.4 |
674 | | GO:0007187 | G\-protein signaling\, coupled to cyclic nucleotide second messenger | 5 | 1021 | 43 | 25211 | 3.85e-02 | 0.00 | 0.00 | 2.9 |
675 | | GO:0007010 | cytoskeleton organization and biogenesis | 9 | 1017 | 100 | 25154 | 3.98e-02 | 0.01 | 0.00 | 2.2 |
676 | | GO:0003007 | heart morphogenesis | 3 | 1023 | 17 | 25237 | 4.12e-02 | 0.00 | 0.00 | 4.3 |
677 | | GO:0006816 | calcium ion transport | 12 | 1014 | 159 | 25095 | 4.50e-02 | 0.01 | 0.01 | 1.9 |
678 | | GO:0048535 | lymph node development | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
679 | | GO:0008631 | induction of apoptosis by oxidative stress | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
680 | | GO:0051482 | elevation of cytosolic calcium ion concentration during G\-protein signaling\, coupled to IP3 second messenger (phospholipase C activating) | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
681 | | GO:0050873 | brown fat cell differentiation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
682 | | GO:0015908 | fatty acid transport | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
683 | | GO:0019222 | regulation of metabolic process | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
684 | | GO:0009650 | UV protection | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
685 | | GO:0048741 | skeletal muscle fiber development | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
686 | | GO:0001841 | neural tube formation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
687 | | GO:0001504 | neurotransmitter uptake | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
688 | | GO:0048011 | nerve growth factor receptor signaling pathway | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
689 | | GO:0045931 | positive regulation of mitotic cell cycle | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
690 | | GO:0045669 | positive regulation of osteoblast differentiation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
691 | | GO:0050853 | B cell receptor signaling pathway | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
692 | | GO:0018106 | peptidyl\-histidine phosphorylation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
693 | | GO:0048839 | inner ear development | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
694 | | GO:0030500 | regulation of bone mineralization | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
695 | | GO:0006029 | proteoglycan metabolic process | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
696 | | GO:0010038 | response to metal ion | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
697 | | GO:0030252 | growth hormone secretion | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
698 | | GO:0030212 | hyaluronan metabolic process | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
699 | | GO:0048598 | embryonic morphogenesis | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
700 | | GO:0030162 | regulation of proteolysis | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
701 | | GO:0006590 | thyroid hormone generation | 2 | 1024 | 7 | 25247 | 4.57e-02 | 0.00 | 0.00 | 7.0 |
702 | | GO:0019722 | calcium\-mediated signaling | 4 | 1022 | 32 | 25222 | 5.06e-02 | 0.00 | 0.00 | 3.1 |
703 | | GO:0043010 | camera\-type eye development | 4 | 1022 | 32 | 25222 | 5.06e-02 | 0.00 | 0.00 | 3.1 |
704 | | GO:0006644 | phospholipid metabolic process | 5 | 1021 | 47 | 25207 | 5.16e-02 | 0.00 | 0.00 | 2.6 |
705 | | GO:0031175 | neurite development | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
706 | | GO:0016485 | protein processing | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
707 | | GO:0030902 | hindbrain development | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
708 | | GO:0016197 | endosome transport | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
709 | | GO:0006904 | vesicle docking during exocytosis | 3 | 1023 | 19 | 25235 | 5.26e-02 | 0.00 | 0.00 | 3.9 |
710 | | GO:0007611 | learning and/or memory | 4 | 1022 | 33 | 25221 | 5.51e-02 | 0.00 | 0.00 | 3.0 |
711 | | GO:0007631 | feeding behavior | 4 | 1022 | 33 | 25221 | 5.51e-02 | 0.00 | 0.00 | 3.0 |
712 | | GO:0001775 | cell activation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
713 | | GO:0030279 | negative regulation of ossification | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
714 | | GO:0030146 | diuresis | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
715 | | GO:0010224 | response to UV\-B | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
716 | | GO:0030307 | positive regulation of cell growth | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
717 | | GO:0007617 | mating behavior | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
718 | | GO:0045745 | positive regulation of G\-protein coupled receptor protein signaling pathway | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
719 | | GO:0001556 | oocyte maturation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
720 | | GO:0007603 | phototransduction\, visible light | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
721 | | GO:0031295 | T cell costimulation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
722 | | GO:0051146 | striated muscle cell differentiation | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
723 | | GO:0015672 | monovalent inorganic cation transport | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
724 | | GO:0015884 | folic acid transport | 2 | 1024 | 8 | 25246 | 5.57e-02 | 0.00 | 0.00 | 6.2 |
725 | | GO:0006897 | endocytosis | 9 | 1017 | 113 | 25141 | 5.74e-02 | 0.01 | 0.00 | 2.0 |
726 | | GO:0006350 | transcription | 86 | 940 | 1718 | 23536 | 5.84e-02 | 0.08 | 0.07 | 1.2 |
727 | | GO:0042060 | wound healing | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
728 | | GO:0007202 | activation of phospholipase C activity | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
729 | | GO:0030199 | collagen fibril organization | 3 | 1023 | 20 | 25234 | 5.88e-02 | 0.00 | 0.00 | 3.7 |
730 | | GO:0006898 | receptor\-mediated endocytosis | 5 | 1021 | 49 | 25205 | 5.90e-02 | 0.00 | 0.00 | 2.5 |
731 | | GO:0016068 | type I hypersensitivity | 5 | 1021 | 50 | 25204 | 6.29e-02 | 0.00 | 0.00 | 2.5 |
732 | | GO:0000910 | cytokinesis | 4 | 1022 | 35 | 25219 | 6.46e-02 | 0.00 | 0.00 | 2.8 |
733 | | GO:0030326 | embryonic limb morphogenesis | 4 | 1022 | 35 | 25219 | 6.46e-02 | 0.00 | 0.00 | 2.8 |
734 | | GO:0007613 | memory | 3 | 1023 | 21 | 25233 | 6.53e-02 | 0.00 | 0.00 | 3.5 |
735 | | GO:0050708 | regulation of protein secretion | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
736 | | GO:0043408 | regulation of MAPKKK cascade | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
737 | | GO:0045727 | positive regulation of translation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
738 | | GO:0014032 | neural crest cell development | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
739 | | GO:0010332 | response to gamma radiation | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
740 | | GO:0006744 | ubiquinone biosynthetic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
741 | | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
742 | | GO:0001975 | response to amphetamine | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
743 | | GO:0006519 | amino acid and derivative metabolic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
744 | | GO:0051457 | maintenance of protein localization in nucleus | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
745 | | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
746 | | GO:0030111 | regulation of Wnt receptor signaling pathway | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
747 | | GO:0048593 | camera\-type eye morphogenesis | 2 | 1024 | 9 | 25245 | 6.63e-02 | 0.00 | 0.00 | 5.5 |
748 | | GO:0006471 | protein amino acid ADP\-ribosylation | 4 | 1022 | 36 | 25218 | 6.96e-02 | 0.00 | 0.00 | 2.7 |
749 | | GO:0006265 | DNA topological change | 4 | 1022 | 36 | 25218 | 6.96e-02 | 0.00 | 0.00 | 2.7 |
750 | | GO:0007566 | embryo implantation | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
751 | | GO:0007269 | neurotransmitter secretion | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
752 | | GO:0007628 | adult walking behavior | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
753 | | GO:0007131 | meiotic recombination | 3 | 1023 | 22 | 25232 | 7.21e-02 | 0.00 | 0.00 | 3.4 |
754 | | GO:0006941 | striated muscle contraction | 4 | 1022 | 37 | 25217 | 7.49e-02 | 0.00 | 0.00 | 2.7 |
755 | | GO:0032287 | myelin maintenance in the peripheral nervous system | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
756 | | GO:0033081 | regulation of T cell differentiation in the thymus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
757 | | GO:0051659 | maintenance of mitochondrion localization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
758 | | GO:0043012 | regulation of fusion of sperm to egg plasma membrane | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
759 | | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
760 | | GO:0001999 | renal response to blood flow during renin\-angiotensin regulation of systemic arterial blood pressure | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
761 | | GO:0002018 | renin\-angiotensin regulation of aldosterone production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
762 | | GO:0002019 | regulation of renal output by angiotensin | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
763 | | GO:0046622 | positive regulation of organ growth | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
764 | | GO:0048143 | astrocyte activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
765 | | GO:0045994 | positive regulation of translational initiation by iron | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
766 | | GO:0002439 | chronic inflammatory response to antigenic stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
767 | | GO:0032722 | positive regulation of chemokine production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
768 | | GO:0045083 | negative regulation of interleukin\-12 biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
769 | | GO:0001315 | age\-dependent response to reactive oxygen species | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
770 | | GO:0043117 | positive regulation of vascular permeability | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
771 | | GO:0009817 | defense response to fungus\, incompatible interaction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
772 | | GO:0042306 | regulation of protein import into nucleus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
773 | | GO:0045066 | regulatory T cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
774 | | GO:0050765 | negative regulation of phagocytosis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
775 | | GO:0051280 | negative regulation of release of sequestered calcium ion into cytosol | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
776 | | GO:0051771 | negative regulation of nitric\-oxide synthase biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
777 | | GO:0042313 | protein kinase C deactivation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
778 | | GO:0007258 | JUN phosphorylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
779 | | GO:0006746 | FADH2 metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
780 | | GO:0010544 | negative regulation of platelet activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
781 | | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
782 | | GO:0032801 | receptor catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
783 | | GO:0009441 | glycolate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
784 | | GO:0033143 | regulation of steroid hormone receptor signaling pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
785 | | GO:0032000 | positive regulation of fatty acid beta\-oxidation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
786 | | GO:0019371 | cyclooxygenase pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
787 | | GO:0009792 | embryonic development ending in birth or egg hatching | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
788 | | GO:0031571 | G1 DNA damage checkpoint | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
789 | | GO:0051097 | negative regulation of helicase activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
790 | | GO:0018144 | RNA\-protein covalent cross\-linking | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
791 | | GO:0006010 | glucose 6\-phosphate utilization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
792 | | GO:0045091 | regulation of retroviral genome replication | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
793 | | GO:0015682 | ferric iron transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
794 | | GO:0031643 | positive regulation of myelination | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
795 | | GO:0006060 | sorbitol metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
796 | | GO:0043305 | negative regulation of mast cell degranulation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
797 | | GO:0043071 | positive regulation of non\-apoptotic programmed cell death | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
798 | | GO:0018894 | dibenzo\-p\-dioxin metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
799 | | GO:0030886 | negative regulation of myeloid dendritic cell activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
800 | | GO:0032695 | negative regulation of interleukin\-12 production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
801 | | GO:0045355 | negative regulation of interferon\-alpha biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
802 | | GO:0051594 | detection of glucose | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
803 | | GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
804 | | GO:0010269 | response to selenium ion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
805 | | GO:0046318 | negative regulation of glucosylceramide biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
806 | | GO:0015866 | ADP transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
807 | | GO:0051024 | positive regulation of immunoglobulin secretion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
808 | | GO:0006642 | triacylglycerol mobilization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
809 | | GO:0002523 | leukocyte migration during inflammatory response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
810 | | GO:0050713 | negative regulation of interleukin\-1 beta secretion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
811 | | GO:0045056 | transcytosis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
812 | | GO:0046628 | positive regulation of insulin receptor signaling pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
813 | | GO:0051385 | response to mineralocorticoid stimulus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
814 | | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
815 | | GO:0000747 | conjugation with cellular fusion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
816 | | GO:0006507 | GPI anchor release | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
817 | | GO:0051603 | proteolysis involved in cellular protein catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
818 | | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
819 | | GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
820 | | GO:0045916 | negative regulation of complement activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
821 | | GO:0021506 | anterior neuropore closure | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
822 | | GO:0048701 | embryonic cranial skeleton morphogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
823 | | GO:0001941 | postsynaptic membrane organization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
824 | | GO:0051584 | regulation of dopamine uptake | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
825 | | GO:0018352 | protein\-pyridoxal\-5\-phosphate linkage | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
826 | | GO:0042840 | D\-glucuronate catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
827 | | GO:0046185 | aldehyde catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
828 | | GO:0030578 | PML body organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
829 | | GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
830 | | GO:0010149 | senescence | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
831 | | GO:0001915 | negative regulation of T cell mediated cytotoxicity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
832 | | GO:0050857 | positive regulation of antigen receptor\-mediated signaling pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
833 | | GO:0010106 | cellular response to iron ion starvation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
834 | | GO:0010046 | response to mycotoxin | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
835 | | GO:0006178 | guanine salvage | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
836 | | GO:0021756 | striatum development | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
837 | | GO:0021895 | cerebral cortex neuron differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
838 | | GO:0045964 | positive regulation of dopamine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
839 | | GO:0046100 | hypoxanthine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
840 | | GO:0016046 | detection of fungus | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
841 | | GO:0032613 | interleukin\-10 production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
842 | | GO:0032615 | interleukin\-12 production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
843 | | GO:0009890 | negative regulation of biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
844 | | GO:0045189 | connective tissue growth factor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
845 | | GO:0006741 | NADP biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
846 | | GO:0006571 | tyrosine biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
847 | | GO:0018126 | protein amino acid hydroxylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
848 | | GO:0046146 | tetrahydrobiopterin metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
849 | | GO:0000115 | S\-phase\-specific transcription in mitotic cell cycle | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
850 | | GO:0045065 | cytotoxic T cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
851 | | GO:0006657 | CDP\-choline pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
852 | | GO:0006894 | Golgi to secretory vesicle transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
853 | | GO:0009651 | response to salt stress | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
854 | | GO:0006543 | glutamine catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
855 | | GO:0046549 | retinal cone cell development | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
856 | | GO:0050771 | negative regulation of axonogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
857 | | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
858 | | GO:0032836 | glomerular basement membrane development | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
859 | | GO:0006264 | mitochondrial DNA replication | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
860 | | GO:0051066 | dihydrobiopterin metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
861 | | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
862 | | GO:0001916 | positive regulation of T cell mediated cytotoxicity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
863 | | GO:0042033 | chemokine biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
864 | | GO:0042231 | interleukin\-13 biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
865 | | GO:0042253 | granulocyte macrophage colony\-stimulating factor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
866 | | GO:0048619 | embryonic hindgut morphogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
867 | | GO:0006581 | acetylcholine catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
868 | | GO:0032223 | negative regulation of synaptic transmission\, cholinergic | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
869 | | GO:0045212 | neurotransmitter receptor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
870 | | GO:0043697 | cell dedifferentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
871 | | GO:0042063 | gliogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
872 | | GO:0048484 | enteric nervous system development | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
873 | | GO:0032388 | positive regulation of intracellular transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
874 | | GO:0046327 | glycerol biosynthetic process from pyruvate | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
875 | | GO:0045063 | T\-helper 1 cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
876 | | GO:0043366 | beta selection | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
877 | | GO:0046638 | positive regulation of alpha\-beta T cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
878 | | GO:0045588 | positive regulation of gamma\-delta T cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
879 | | GO:0006585 | dopamine biosynthetic process from tyrosine | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
880 | | GO:0043400 | cortisol secretion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
881 | | GO:0019310 | inositol catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
882 | | GO:0014067 | negative regulation of phosphoinositide 3\-kinase cascade | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
883 | | GO:0033364 | mast cell secretory granule organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
884 | | GO:0033371 | T cell secretory granule organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
885 | | GO:0033373 | maintenance of protease localization in mast cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
886 | | GO:0033382 | maintenance of granzyme B localization in T cell secretory granule | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
887 | | GO:0042489 | negative regulation of odontogenesis of dentine\-containing teeth | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
888 | | GO:0043558 | regulation of translational initiation in response to stress | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
889 | | GO:0001825 | blastocyst formation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
890 | | GO:0051646 | mitochondrion localization | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
891 | | GO:0030913 | paranodal junction assembly | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
892 | | GO:0043568 | positive regulation of insulin\-like growth factor receptor signaling pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
893 | | GO:0051963 | regulation of synaptogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
894 | | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
895 | | GO:0045103 | intermediate filament\-based process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
896 | | GO:0016445 | somatic diversification of immunoglobulins | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
897 | | GO:0060155 | platelet dense granule organization and biogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
898 | | GO:0045906 | negative regulation of vasoconstriction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
899 | | GO:0055088 | lipid homeostasis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
900 | | GO:0002227 | innate immune response in mucosa | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
901 | | GO:0042160 | lipoprotein modification | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
902 | | GO:0044240 | multicellular organismal lipid catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
903 | | GO:0065005 | protein\-lipid complex assembly | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
904 | | GO:0050666 | regulation of homocysteine metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
905 | | GO:0009854 | oxidative photosynthetic carbon pathway | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
906 | | GO:0032344 | regulation of aldosterone metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
907 | | GO:0045794 | negative regulation of cell volume | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
908 | | GO:0060082 | eye blink reflex | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
909 | | GO:0001878 | response to yeast | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
910 | | GO:0008627 | induction of apoptosis by ionic changes | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
911 | | GO:0007228 | positive regulation of hh target transcription factor activity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
912 | | GO:0032435 | negative regulation of proteasomal ubiquitin\-dependent protein catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
913 | | GO:0046639 | negative regulation of alpha\-beta T cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
914 | | GO:0060020 | Bergmann glial cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
915 | | GO:0019682 | glyceraldehyde\-3\-phosphate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
916 | | GO:0043308 | eosinophil degranulation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
917 | | GO:0043312 | neutrophil degranulation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
918 | | GO:0006554 | lysine catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
919 | | GO:0009448 | gamma\-aminobutyric acid metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
920 | | GO:0001777 | T cell homeostatic proliferation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
921 | | GO:0002358 | B cell homeostatic proliferation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
922 | | GO:0032976 | release of matrix enzymes from mitochondria | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
923 | | GO:0046674 | induction of retinal programmed cell death | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
924 | | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
925 | | GO:0046314 | phosphocreatine biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
926 | | GO:0005997 | xylulose metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
927 | | GO:0030422 | RNA interference\, production of siRNA | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
928 | | GO:0030423 | RNA interference\, targeting of mRNA for destruction | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
929 | | GO:0002539 | prostaglandin production during acute inflammatory response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
930 | | GO:0017144 | drug metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
931 | | GO:0043651 | linoleic acid metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
932 | | GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
933 | | GO:0048333 | mesodermal cell differentiation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
934 | | GO:0000023 | maltose metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
935 | | GO:0005985 | sucrose metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
936 | | GO:0043181 | vacuolar sequestering | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
937 | | GO:0046477 | glycosylceramide catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
938 | | GO:0046479 | glycosphingolipid catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
939 | | GO:0042262 | DNA protection | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
940 | | GO:0006538 | glutamate catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
941 | | GO:0001661 | conditioned taste aversion | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
942 | | GO:0042026 | protein refolding | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
943 | | GO:0042685 | cardioblast cell fate specification | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
944 | | GO:0051249 | regulation of lymphocyte activation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
945 | | GO:0046340 | diacylglycerol catabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
946 | | GO:0051569 | regulation of histone H3\-K4 methylation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
947 | | GO:0050768 | negative regulation of neurogenesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
948 | | GO:0051106 | positive regulation of DNA ligation | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
949 | | GO:0050848 | regulation of calcium\-mediated signaling | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
950 | | GO:0006994 | positive regulation of sterol regulatory element binding protein target gene transcription involved in sterol depletion response | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
951 | | GO:0045716 | positive regulation of low\-density lipoprotein receptor biosynthetic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
952 | | GO:0006843 | mitochondrial citrate transport | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
953 | | GO:0001780 | neutrophil homeostasis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
954 | | GO:0006089 | lactate metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
955 | | GO:0032682 | negative regulation of chemokine production | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
956 | | GO:0035166 | post\-embryonic hemopoiesis | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
957 | | GO:0007403 | glial cell fate determination | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
958 | | GO:0006662 | glycerol ether metabolic process | 1 | 1025 | 1 | 25253 | 7.66e-02 | 0.00 | 0.00 | 24.6 |
959 | | GO:0001932 | regulation of protein amino acid phosphorylation | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
960 | | GO:0043193 | positive regulation of gene\-specific transcription | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
961 | | GO:0042640 | anagen | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
962 | | GO:0007589 | body fluid secretion | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
963 | | GO:0048168 | regulation of neuronal synaptic plasticity | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
964 | | GO:0030833 | regulation of actin filament polymerization | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
965 | | GO:0045768 | positive regulation of anti\-apoptosis | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
966 | | GO:0043154 | negative regulation of caspase activity | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
967 | | GO:0006261 | DNA\-dependent DNA replication | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
968 | | GO:0006476 | protein amino acid deacetylation | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
969 | | GO:0009268 | response to pH | 2 | 1024 | 10 | 25244 | 7.76e-02 | 0.00 | 0.00 | 4.9 |
970 | | GO:0019538 | protein metabolic process | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
971 | | GO:0006909 | phagocytosis | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
972 | | GO:0030178 | negative regulation of Wnt receptor signaling pathway | 3 | 1023 | 23 | 25231 | 7.93e-02 | 0.00 | 0.00 | 3.2 |
973 | | GO:0006333 | chromatin assembly or disassembly | 5 | 1021 | 54 | 25200 | 7.99e-02 | 0.00 | 0.00 | 2.3 |
974 | | GO:0001558 | regulation of cell growth | 8 | 1018 | 103 | 25151 | 8.10e-02 | 0.01 | 0.00 | 1.9 |
975 | | GO:0007265 | Ras protein signal transduction | 4 | 1022 | 39 | 25215 | 8.60e-02 | 0.00 | 0.00 | 2.5 |
976 | | GO:0006493 | protein amino acid O\-linked glycosylation | 3 | 1023 | 24 | 25230 | 8.67e-02 | 0.00 | 0.00 | 3.1 |
977 | | GO:0007015 | actin filament organization | 3 | 1023 | 24 | 25230 | 8.67e-02 | 0.00 | 0.00 | 3.1 |
978 | | GO:0031069 | hair follicle morphogenesis | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
979 | | GO:0045453 | bone resorption | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
980 | | GO:0006342 | chromatin silencing | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
981 | | GO:0019953 | sexual reproduction | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
982 | | GO:0030520 | estrogen receptor signaling pathway | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
983 | | GO:0008045 | motor axon guidance | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
984 | | GO:0009086 | methionine biosynthetic process | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
985 | | GO:0006857 | oligopeptide transport | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
986 | | GO:0050766 | positive regulation of phagocytosis | 2 | 1024 | 11 | 25243 | 8.94e-02 | 0.00 | 0.00 | 4.5 |
987 | | GO:0007420 | brain development | 8 | 1018 | 107 | 25147 | 9.14e-02 | 0.01 | 0.00 | 1.8 |
988 | | GO:0009409 | response to cold | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
989 | | GO:0006707 | cholesterol catabolic process | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
990 | | GO:0016064 | immunoglobulin mediated immune response | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
991 | | GO:0006940 | regulation of smooth muscle contraction | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
992 | | GO:0030539 | male genitalia development | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
993 | | GO:0006378 | mRNA polyadenylation | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
994 | | GO:0048041 | focal adhesion formation | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
995 | | GO:0050808 | synapse organization and biogenesis | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
996 | | GO:0043113 | receptor clustering | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
997 | | GO:0035116 | embryonic hindlimb morphogenesis | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
998 | | GO:0007492 | endoderm development | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
999 | | GO:0009954 | proximal/distal pattern formation | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
1000 | | GO:0048663 | neuron fate commitment | 2 | 1024 | 12 | 25242 | 1.02e-01 | 0.00 | 0.00 | 4.1 |
1001 | | GO:0006606 | protein import into nucleus | 3 | 1023 | 26 | 25228 | 1.02e-01 | 0.00 | 0.00 | 2.8 |
1002 | | GO:0006417 | regulation of translation | 4 | 1022 | 43 | 25211 | 1.10e-01 | 0.00 | 0.00 | 2.3 |
1003 | | GO:0006796 | phosphate metabolic process | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
1004 | | GO:0006289 | nucleotide\-excision repair | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
1005 | | GO:0006298 | mismatch repair | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
1006 | | GO:0007190 | activation of adenylate cyclase activity | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
1007 | | GO:0008584 | male gonad development | 3 | 1023 | 27 | 25227 | 1.11e-01 | 0.00 | 0.00 | 2.7 |
1008 | | GO:0046631 | alpha\-beta T cell activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1009 | | GO:0002262 | myeloid cell homeostasis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1010 | | GO:0043072 | negative regulation of non\-apoptotic programmed cell death | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1011 | | GO:0010155 | regulation of proton transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1012 | | GO:0050663 | cytokine secretion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1013 | | GO:0001543 | ovarian follicle rupture | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1014 | | GO:0042756 | drinking behavior | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1015 | | GO:0048659 | smooth muscle cell proliferation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1016 | | GO:0051926 | negative regulation of calcium ion transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1017 | | GO:0019858 | cytosine metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1018 | | GO:0009967 | positive regulation of signal transduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1019 | | GO:0048298 | positive regulation of isotype switching to IgA isotypes | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1020 | | GO:0035307 | positive regulation of protein amino acid dephosphorylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1021 | | GO:0051290 | protein heterotetramerization | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1022 | | GO:0035026 | leading edge cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1023 | | GO:0019934 | cGMP\-mediated signaling | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1024 | | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1025 | | GO:0050872 | white fat cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1026 | | GO:0006925 | inflammatory cell apoptosis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1027 | | GO:0032735 | positive regulation of interleukin\-12 production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1028 | | GO:0032848 | negative regulation of cellular pH reduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1029 | | GO:0000819 | sister chromatid segregation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1030 | | GO:0051453 | regulation of intracellular pH | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1031 | | GO:0035025 | positive regulation of Rho protein signal transduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1032 | | GO:0048261 | negative regulation of receptor\-mediated endocytosis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1033 | | GO:0032764 | negative regulation of mast cell cytokine production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1034 | | GO:0019372 | lipoxygenase pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1035 | | GO:0045192 | low\-density lipoprotein catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1036 | | GO:0045347 | negative regulation of MHC class II biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1037 | | GO:0035066 | positive regulation of histone acetylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1038 | | GO:0046321 | positive regulation of fatty acid oxidation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1039 | | GO:0040029 | regulation of gene expression\, epigenetic | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1040 | | GO:0045542 | positive regulation of cholesterol biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1041 | | GO:0015867 | ATP transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1042 | | GO:0043149 | stress fiber formation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1043 | | GO:0009629 | response to gravity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1044 | | GO:0046838 | phosphorylated carbohydrate dephosphorylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1045 | | GO:0046415 | urate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1046 | | GO:0043006 | calcium\-dependent phospholipase A2 activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1047 | | GO:0050999 | regulation of nitric\-oxide synthase activity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1048 | | GO:0006107 | oxaloacetate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1049 | | GO:0015936 | coenzyme A metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1050 | | GO:0032792 | inhibition of CREB transcription factor | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1051 | | GO:0055009 | atrial cardiac muscle morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1052 | | GO:0000183 | chromatin silencing at rDNA | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1053 | | GO:0006348 | chromatin silencing at telomere | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1054 | | GO:0019853 | L\-ascorbic acid biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1055 | | GO:0021904 | dorsoventral neural tube patterning | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1056 | | GO:0032331 | negative regulation of chondrocyte differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1057 | | GO:0001544 | initiation of primordial ovarian follicle growth | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1058 | | GO:0001547 | antral ovarian follicle growth | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1059 | | GO:0043030 | regulation of macrophage activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1060 | | GO:0033088 | negative regulation of immature T cell proliferation in the thymus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1061 | | GO:0001960 | negative regulation of cytokine and chemokine mediated signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1062 | | GO:0002378 | immunoglobulin biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1063 | | GO:0006168 | adenine salvage | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1064 | | GO:0021954 | central nervous system neuron development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1065 | | GO:0046058 | cAMP metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1066 | | GO:0048295 | positive regulation of isotype switching to IgE isotypes | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1067 | | GO:0042450 | arginine biosynthetic process via ornithine | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1068 | | GO:0000053 | argininosuccinate metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1069 | | GO:0015961 | diadenosine polyphosphate catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1070 | | GO:0045910 | negative regulation of DNA recombination | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1071 | | GO:0006663 | platelet activating factor biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1072 | | GO:0048102 | autophagic cell death | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1073 | | GO:0018343 | protein farnesylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1074 | | GO:0030823 | regulation of cGMP metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1075 | | GO:0045821 | positive regulation of glycolysis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1076 | | GO:0034097 | response to cytokine stimulus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1077 | | GO:0006097 | glyoxylate cycle | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1078 | | GO:0006880 | intracellular sequestering of iron ion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1079 | | GO:0007616 | long\-term memory | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1080 | | GO:0046827 | positive regulation of protein export from nucleus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1081 | | GO:0032816 | positive regulation of natural killer cell activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1082 | | GO:0042095 | interferon\-gamma biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1083 | | GO:0030538 | embryonic genitalia morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1084 | | GO:0048557 | embryonic digestive tract morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1085 | | GO:0001507 | acetylcholine catabolic process in synaptic cleft | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1086 | | GO:0042982 | amyloid precursor protein metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1087 | | GO:0032417 | positive regulation of sodium\:hydrogen antiporter activity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1088 | | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1089 | | GO:0001838 | embryonic epithelial tube formation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1090 | | GO:0006475 | internal protein amino acid acetylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1091 | | GO:0042490 | mechanoreceptor differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1092 | | GO:0045634 | regulation of melanocyte differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1093 | | GO:0051549 | positive regulation of keratinocyte migration | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1094 | | GO:0040013 | negative regulation of locomotion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1095 | | GO:0051965 | positive regulation of synaptogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1096 | | GO:0046626 | regulation of insulin receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1097 | | GO:0050918 | positive chemotaxis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1098 | | GO:0050779 | RNA destabilization | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1099 | | GO:0002507 | tolerance induction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1100 | | GO:0046580 | negative regulation of Ras protein signal transduction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1101 | | GO:0022617 | extracellular matrix disassembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1102 | | GO:0031581 | hemidesmosome assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1103 | | GO:0001867 | complement activation\, lectin pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1104 | | GO:0019102 | male somatic sex determination | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1105 | | GO:0050702 | interleukin\-1 beta secretion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1106 | | GO:0032374 | regulation of cholesterol transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1107 | | GO:0055090 | acylglycerol homeostasis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1108 | | GO:0042159 | lipoprotein catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1109 | | GO:0006931 | substrate\-bound cell migration\, cell attachment to substrate | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1110 | | GO:0032023 | trypsinogen activation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1111 | | GO:0006582 | melanin metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1112 | | GO:0021631 | optic nerve morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1113 | | GO:0002755 | MyD88\-dependent toll\-like receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1114 | | GO:0006591 | ornithine metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1115 | | GO:0016539 | intein\-mediated protein splicing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1116 | | GO:0045780 | positive regulation of bone resorption | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1117 | | GO:0030323 | respiratory tube development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1118 | | GO:0009450 | gamma\-aminobutyric acid catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1119 | | GO:0006649 | phospholipid transfer to membrane | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1120 | | GO:0032914 | positive regulation of transforming growth factor\-beta1 production | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1121 | | GO:0001783 | B cell apoptosis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1122 | | GO:0001844 | protein insertion into mitochondrial membrane during induction of apoptosis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1123 | | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1124 | | GO:0035051 | cardiac cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1125 | | GO:0048711 | positive regulation of astrocyte differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1126 | | GO:0032582 | negative regulation of gene\-specific transcription | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1127 | | GO:0001913 | T cell mediated cytotoxicity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1128 | | GO:0051606 | detection of stimulus | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1129 | | GO:0031579 | membrane raft organization and biogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1130 | | GO:0002064 | epithelial cell development | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1131 | | GO:0045136 | development of secondary sexual characteristics | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1132 | | GO:0060046 | regulation of acrosome reaction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1133 | | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1134 | | GO:0060055 | angiogenesis involved in wound healing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1135 | | GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1136 | | GO:0002315 | marginal zone B cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1137 | | GO:0019730 | antimicrobial humoral response | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1138 | | GO:0045064 | T\-helper 2 cell differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1139 | | GO:0031333 | negative regulation of protein complex assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1140 | | GO:0050790 | regulation of catalytic activity | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1141 | | GO:0042732 | D\-xylose metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1142 | | GO:0035196 | gene silencing by miRNA\, production of miRNAs | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1143 | | GO:0019439 | aromatic compound catabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1144 | | GO:0051928 | positive regulation of calcium ion transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1145 | | GO:0001957 | intramembranous ossification | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1146 | | GO:0006463 | steroid hormone receptor complex assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1147 | | GO:0046661 | male sex differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1148 | | GO:0046655 | folic acid metabolic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1149 | | GO:0002086 | diaphragm contraction | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1150 | | GO:0006601 | creatine biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1151 | | GO:0045019 | negative regulation of nitric oxide biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1152 | | GO:0010226 | response to lithium ion | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1153 | | GO:0021575 | hindbrain morphogenesis | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1154 | | GO:0051966 | regulation of synaptic transmission\, glutamatergic | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1155 | | GO:0033159 | negative regulation of protein import into nucleus\, translocation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1156 | | GO:0050732 | negative regulation of peptidyl\-tyrosine phosphorylation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1157 | | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1158 | | GO:0010002 | cardioblast differentiation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1159 | | GO:0050856 | regulation of T cell receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1160 | | GO:0050862 | positive regulation of T cell receptor signaling pathway | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1161 | | GO:0006023 | aminoglycan biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1162 | | GO:0015888 | thiamin transport | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1163 | | GO:0006167 | AMP biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1164 | | GO:0043122 | regulation of I\-kappaB kinase/NF\-kappaB cascade | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1165 | | GO:0007144 | female meiosis I | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1166 | | GO:0002636 | positive regulation of germinal center formation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1167 | | GO:0031296 | B cell costimulation | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1168 | | GO:0012501 | programmed cell death | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1169 | | GO:0006587 | serotonin biosynthetic process from tryptophan | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1170 | | GO:0042427 | serotonin biosynthetic process | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1171 | | GO:0000729 | DNA double\-strand break processing | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1172 | | GO:0043297 | apical junction assembly | 1 | 1025 | 2 | 25252 | 1.13e-01 | 0.00 | 0.00 | 12.3 |
1173 | | GO:0006754 | ATP biosynthetic process | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1174 | | GO:0010165 | response to X\-ray | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1175 | | GO:0048167 | regulation of synaptic plasticity | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1176 | | GO:0007512 | adult heart development | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1177 | | GO:0006081 | aldehyde metabolic process | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1178 | | GO:0045444 | fat cell differentiation | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1179 | | GO:0050832 | defense response to fungus | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1180 | | GO:0016573 | histone acetylation | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1181 | | GO:0009060 | aerobic respiration | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1182 | | GO:0008344 | adult locomotory behavior | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1183 | | GO:0001708 | cell fate specification | 2 | 1024 | 13 | 25241 | 1.14e-01 | 0.00 | 0.00 | 3.8 |
1184 | | GO:0006865 | amino acid transport | 4 | 1022 | 44 | 25210 | 1.17e-01 | 0.00 | 0.00 | 2.2 |
1185 | | GO:0006725 | aromatic compound metabolic process | 3 | 1023 | 28 | 25226 | 1.19e-01 | 0.00 | 0.00 | 2.6 |
1186 | | GO:0006811 | ion transport | 33 | 993 | 611 | 24643 | 1.21e-01 | 0.03 | 0.02 | 1.3 |
1187 | | GO:0007612 | learning | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1188 | | GO:0018105 | peptidyl\-serine phosphorylation | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1189 | | GO:0000723 | telomere maintenance | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1190 | | GO:0009987 | cellular process | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1191 | | GO:0008206 | bile acid metabolic process | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1192 | | GO:0030073 | insulin secretion | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1193 | | GO:0044262 | cellular carbohydrate metabolic process | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1194 | | GO:0007398 | ectoderm development | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1195 | | GO:0042325 | regulation of phosphorylation | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1196 | | GO:0006996 | organelle organization and biogenesis | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1197 | | GO:0006024 | glycosaminoglycan biosynthetic process | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1198 | | GO:0030048 | actin filament\-based movement | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1199 | | GO:0000724 | double\-strand break repair via homologous recombination | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1200 | | GO:0050819 | negative regulation of coagulation | 2 | 1024 | 14 | 25240 | 1.27e-01 | 0.00 | 0.00 | 3.5 |
1201 | | GO:0030855 | epithelial cell differentiation | 3 | 1023 | 29 | 25225 | 1.28e-01 | 0.00 | 0.00 | 2.5 |
1202 | | GO:0006182 | cGMP biosynthetic process | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
1203 | | GO:0010001 | glial cell differentiation | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
1204 | | GO:0046847 | filopodium formation | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
1205 | | GO:0006275 | regulation of DNA replication | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
1206 | | GO:0000209 | protein polyubiquitination | 2 | 1024 | 15 | 25239 | 1.41e-01 | 0.00 | 0.00 | 3.3 |
1207 | | GO:0009306 | protein secretion | 3 | 1023 | 31 | 25223 | 1.46e-01 | 0.00 | 0.00 | 2.4 |
1208 | | GO:0016339 | calcium\-dependent cell\-cell adhesion | 3 | 1023 | 31 | 25223 | 1.46e-01 | 0.00 | 0.00 | 2.4 |
1209 | | GO:0045908 | negative regulation of vasodilation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1210 | | GO:0007199 | G\-protein signaling\, coupled to cGMP nucleotide second messenger | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1211 | | GO:0008065 | establishment of blood\-nerve barrier | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1212 | | GO:0045884 | regulation of survival gene product expression | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1213 | | GO:0045630 | positive regulation of T\-helper 2 cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1214 | | GO:0046007 | negative regulation of activated T cell proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1215 | | GO:0031583 | G\-protein signaling\, phospholipase D activating pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1216 | | GO:0043179 | rhythmic excitation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1217 | | GO:0030300 | regulation of cholesterol absorption | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1218 | | GO:0032099 | negative regulation of appetite | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1219 | | GO:0045639 | positive regulation of myeloid cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1220 | | GO:0051902 | negative regulation of mitochondrial depolarization | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1221 | | GO:0042149 | cellular response to glucose starvation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1222 | | GO:0002347 | response to tumor cell | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1223 | | GO:0051048 | negative regulation of secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1224 | | GO:0045817 | positive regulation of transcription from RNA polymerase II promoter\, global | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1225 | | GO:0006970 | response to osmotic stress | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1226 | | GO:0031589 | cell\-substrate adhesion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1227 | | GO:0045725 | positive regulation of glycogen biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1228 | | GO:0055008 | cardiac muscle morphogensis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1229 | | GO:0007176 | regulation of epidermal growth factor receptor activity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1230 | | GO:0051935 | glutamate uptake during transmission of nerve impulse | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1231 | | GO:0050672 | negative regulation of lymphocyte proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1232 | | GO:0019852 | L\-ascorbic acid metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1233 | | GO:0032436 | positive regulation of proteasomal ubiquitin\-dependent protein catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1234 | | GO:0001101 | response to acid | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1235 | | GO:0007320 | insemination | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1236 | | GO:0006200 | ATP catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1237 | | GO:0045058 | T cell selection | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1238 | | GO:0006545 | glycine biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1239 | | GO:0017055 | negative regulation of transcriptional preinitiation complex assembly | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1240 | | GO:0042488 | positive regulation of odontogenesis of dentine\-containing teeth | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1241 | | GO:0000320 | re\-entry into mitotic cell cycle | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1242 | | GO:0046651 | lymphocyte proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1243 | | GO:0042116 | macrophage activation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1244 | | GO:0009228 | thiamin biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1245 | | GO:0042404 | thyroid hormone catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1246 | | GO:0055012 | ventricular cardiac muscle cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1247 | | GO:0022008 | neurogenesis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1248 | | GO:0042448 | progesterone metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1249 | | GO:0002456 | T cell mediated immunity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1250 | | GO:0016447 | somatic recombination of immunoglobulin gene segments | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1251 | | GO:0010552 | positive regulation of specific transcription from RNA polymerase II promoter | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1252 | | GO:0002088 | lens development in camera\-type eye | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1253 | | GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1254 | | GO:0042094 | interleukin\-2 biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1255 | | GO:0048549 | positive regulation of pinocytosis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1256 | | GO:0006335 | DNA replication\-dependent nucleosome assembly | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1257 | | GO:0046498 | S\-adenosylhomocysteine metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1258 | | GO:0046500 | S\-adenosylmethionine metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1259 | | GO:0006481 | C\-terminal protein amino acid methylation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1260 | | GO:0007412 | axon target recognition | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1261 | | GO:0046641 | positive regulation of alpha\-beta T cell proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1262 | | GO:0045401 | positive regulation of interleukin\-3 biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1263 | | GO:0001820 | serotonin secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1264 | | GO:0046676 | negative regulation of insulin secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1265 | | GO:0060079 | regulation of excitatory postsynaptic membrane potential | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1266 | | GO:0045767 | regulation of anti\-apoptosis | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1267 | | GO:0051967 | negative regulation of synaptic transmission\, glutamatergic | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1268 | | GO:0007208 | serotonin receptor\, phospholipase C activating pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1269 | | GO:0016925 | protein sumoylation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1270 | | GO:0032880 | regulation of protein localization | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1271 | | GO:0046649 | lymphocyte activation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1272 | | GO:0045879 | negative regulation of smoothened signaling pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1273 | | GO:0045687 | positive regulation of glial cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1274 | | GO:0006426 | glycyl\-tRNA aminoacylation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1275 | | GO:0000022 | mitotic spindle elongation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1276 | | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1277 | | GO:0033077 | T cell differentiation in the thymus | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1278 | | GO:0042312 | regulation of vasodilation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1279 | | GO:0045475 | locomotor rhythm | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1280 | | GO:0060083 | smooth muscle contraction involved in micturition | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1281 | | GO:0035295 | tube development | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1282 | | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1283 | | GO:0021776 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1284 | | GO:0048646 | anatomical structure formation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1285 | | GO:0002238 | response to molecule of fungal origin | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1286 | | GO:0000915 | cytokinesis\, contractile ring formation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1287 | | GO:0007108 | cytokinesis\, initiation of separation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1288 | | GO:0007418 | ventral midline development | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1289 | | GO:0050678 | regulation of epithelial cell proliferation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1290 | | GO:0015909 | long\-chain fatty acid transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1291 | | GO:0006922 | cleavage of lamin | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1292 | | GO:0043409 | negative regulation of MAPKKK cascade | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1293 | | GO:0051925 | regulation of calcium ion transport via voltage\-gated calcium channel | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1294 | | GO:0002526 | acute inflammatory response | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1295 | | GO:0051270 | regulation of cell motility | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1296 | | GO:0046339 | diacylglycerol metabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1297 | | GO:0015014 | heparan sulfate proteoglycan biosynthetic process\, polysaccharide chain biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1298 | | GO:0007529 | establishment of synaptic specificity at neuromuscular junction | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1299 | | GO:0006123 | mitochondrial electron transport\, cytochrome c to oxygen | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1300 | | GO:0006784 | heme a biosynthetic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1301 | | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1302 | | GO:0045663 | positive regulation of myoblast differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1303 | | GO:0048505 | regulation of timing of cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1304 | | GO:0007309 | oocyte axis determination | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1305 | | GO:0000066 | mitochondrial ornithine transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1306 | | GO:0045746 | negative regulation of Notch signaling pathway | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1307 | | GO:0009166 | nucleotide catabolic process | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1308 | | GO:0015755 | fructose transport | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1309 | | GO:0002318 | myeloid progenitor cell differentiation | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1310 | | GO:0006346 | methylation\-dependent chromatin silencing | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1311 | | GO:0048305 | immunoglobulin secretion | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1312 | | GO:0040016 | embryonic cleavage | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1313 | | GO:0043405 | regulation of MAP kinase activity | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1314 | | GO:0006122 | mitochondrial electron transport\, ubiquinol to cytochrome c | 1 | 1025 | 3 | 25251 | 1.47e-01 | 0.00 | 0.00 | 8.2 |
1315 | | GO:0009790 | embryonic development | 4 | 1022 | 49 | 25205 | 1.52e-01 | 0.00 | 0.00 | 2.0 |
1316 | | GO:0007409 | axonogenesis | 4 | 1022 | 49 | 25205 | 1.52e-01 | 0.00 | 0.00 | 2.0 |
1317 | | GO:0006825 | copper ion transport | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
1318 | | GO:0030101 | natural killer cell activation | 2 | 1024 | 16 | 25238 | 1.55e-01 | 0.00 | 0.00 | 3.1 |
1319 | | GO:0045087 | innate immune response | 6 | 1020 | 81 | 25173 | 1.56e-01 | 0.01 | 0.00 | 1.8 |
1320 | | GO:0007389 | pattern specification process | 3 | 1023 | 33 | 25221 | 1.65e-01 | 0.00 | 0.00 | 2.2 |
1321 | | GO:0007271 | synaptic transmission\, cholinergic | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
1322 | | GO:0009314 | response to radiation | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
1323 | | GO:0046839 | phospholipid dephosphorylation | 2 | 1024 | 17 | 25237 | 1.69e-01 | 0.00 | 0.00 | 2.9 |
1324 | | GO:0005978 | glycogen biosynthetic process | 3 | 1023 | 34 | 25220 | 1.74e-01 | 0.00 | 0.00 | 2.2 |
1325 | | GO:0001819 | positive regulation of cytokine production | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1326 | | GO:0019836 | hemolysis by symbiont of host red blood cells | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1327 | | GO:0042474 | middle ear morphogenesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1328 | | GO:0030195 | negative regulation of blood coagulation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1329 | | GO:0040009 | regulation of growth rate | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1330 | | GO:0032755 | positive regulation of interleukin\-6 production | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1331 | | GO:0030828 | positive regulation of cGMP biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1332 | | GO:0031642 | negative regulation of myelination | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1333 | | GO:0007207 | muscarinic acetylcholine receptor\, phospholipase C activating pathway | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1334 | | GO:0040012 | regulation of locomotion | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1335 | | GO:0050905 | neuromuscular process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1336 | | GO:0031016 | pancreas development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1337 | | GO:0055003 | cardiac myofibril assembly | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1338 | | GO:0000002 | mitochondrial genome maintenance | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1339 | | GO:0032364 | oxygen homeostasis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1340 | | GO:0045762 | positive regulation of adenylate cyclase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1341 | | GO:0009582 | detection of abiotic stimulus | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1342 | | GO:0050769 | positive regulation of neurogenesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1343 | | GO:0006687 | glycosphingolipid metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1344 | | GO:0006288 | base\-excision repair\, DNA ligation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1345 | | GO:0030278 | regulation of ossification | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1346 | | GO:0046579 | positive regulation of Ras protein signal transduction | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1347 | | GO:0006163 | purine nucleotide metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1348 | | GO:0048103 | somatic stem cell division | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1349 | | GO:0045737 | positive regulation of cyclin\-dependent protein kinase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1350 | | GO:0033261 | regulation of S phase | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1351 | | GO:0006166 | purine ribonucleoside salvage | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1352 | | GO:0006726 | eye pigment biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1353 | | GO:0007252 | I\-kappaB phosphorylation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1354 | | GO:0006766 | vitamin metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1355 | | GO:0051005 | negative regulation of lipoprotein lipase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1356 | | GO:0000105 | histidine biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1357 | | GO:0048699 | generation of neurons | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1358 | | GO:0045604 | regulation of epidermal cell differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1359 | | GO:0008218 | bioluminescence | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1360 | | GO:0045124 | regulation of bone resorption | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1361 | | GO:0006432 | phenylalanyl\-tRNA aminoacylation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1362 | | GO:0018401 | peptidyl\-proline hydroxylation to 4\-hydroxy\-L\-proline | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1363 | | GO:0050714 | positive regulation of protein secretion | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1364 | | GO:0042221 | response to chemical stimulus | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1365 | | GO:0006474 | N\-terminal protein amino acid acetylation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1366 | | GO:0043206 | fibril organization and biogenesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1367 | | GO:0016322 | neuron remodeling | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1368 | | GO:0045425 | positive regulation of granulocyte macrophage colony\-stimulating factor biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1369 | | GO:0043306 | positive regulation of mast cell degranulation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1370 | | GO:0001963 | synaptic transmission\, dopaminergic | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1371 | | GO:0000281 | cytokinesis after mitosis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1372 | | GO:0016079 | synaptic vesicle exocytosis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1373 | | GO:0050804 | regulation of synaptic transmission | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1374 | | GO:0001778 | plasma membrane repair | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1375 | | GO:0033151 | V(D)J recombination | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1376 | | GO:0050892 | intestinal absorption | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1377 | | GO:0032367 | intracellular cholesterol transport | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1378 | | GO:0016458 | gene silencing | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1379 | | GO:0046541 | saliva secretion | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1380 | | GO:0048558 | embryonic gut morphogenesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1381 | | GO:0008063 | Toll signaling pathway | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1382 | | GO:0008228 | opsonization | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1383 | | GO:0006569 | tryptophan catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1384 | | GO:0002052 | positive regulation of neuroblast proliferation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1385 | | GO:0042993 | positive regulation of transcription factor import into nucleus | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1386 | | GO:0032743 | positive regulation of interleukin\-2 production | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1387 | | GO:0048148 | behavioral response to cocaine | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1388 | | GO:0006907 | pinocytosis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1389 | | GO:0046329 | negative regulation of JNK cascade | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1390 | | GO:0043281 | regulation of caspase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1391 | | GO:0060011 | Sertoli cell proliferation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1392 | | GO:0045778 | positive regulation of ossification | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1393 | | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1394 | | GO:0010225 | response to UV\-C | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1395 | | GO:0007097 | nuclear migration | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1396 | | GO:0045777 | positive regulation of blood pressure | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1397 | | GO:0002063 | chondrocyte development | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1398 | | GO:0031503 | protein complex localization | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1399 | | GO:0042596 | fear response | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1400 | | GO:0045216 | cell\-cell junction assembly and maintenance | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1401 | | GO:0045880 | positive regulation of smoothened signaling pathway | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1402 | | GO:0019433 | triacylglycerol catabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1403 | | GO:0035162 | embryonic hemopoiesis | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1404 | | GO:0006555 | methionine metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1405 | | GO:0030091 | protein repair | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1406 | | GO:0019933 | cAMP\-mediated signaling | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1407 | | GO:0045638 | negative regulation of myeloid cell differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1408 | | GO:0006564 | L\-serine biosynthetic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1409 | | GO:0032781 | positive regulation of ATPase activity | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1410 | | GO:0045730 | respiratory burst | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1411 | | GO:0001832 | blastocyst growth | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1412 | | GO:0001835 | blastocyst hatching | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1413 | | GO:0006684 | sphingomyelin metabolic process | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1414 | | GO:0030098 | lymphocyte differentiation | 1 | 1025 | 4 | 25250 | 1.81e-01 | 0.00 | 0.00 | 6.2 |
1415 | | GO:0018298 | protein\-chromophore linkage | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
1416 | | GO:0051017 | actin filament bundle formation | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
1417 | | GO:0051259 | protein oligomerization | 2 | 1024 | 18 | 25236 | 1.83e-01 | 0.00 | 0.00 | 2.7 |
1418 | | GO:0030163 | protein catabolic process | 3 | 1023 | 35 | 25219 | 1.84e-01 | 0.00 | 0.00 | 2.1 |
1419 | | GO:0007283 | spermatogenesis | 14 | 1012 | 243 | 25011 | 1.94e-01 | 0.01 | 0.01 | 1.4 |
1420 | | GO:0006120 | mitochondrial electron transport\, NADH to ubiquinone | 3 | 1023 | 36 | 25218 | 1.94e-01 | 0.00 | 0.00 | 2.1 |
1421 | | GO:0001889 | liver development | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
1422 | | GO:0007528 | neuromuscular junction development | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
1423 | | GO:0008542 | visual learning | 2 | 1024 | 19 | 25235 | 1.97e-01 | 0.00 | 0.00 | 2.6 |
1424 | | GO:0030216 | keratinocyte differentiation | 3 | 1023 | 37 | 25217 | 2.04e-01 | 0.00 | 0.00 | 2.0 |
1425 | | GO:0016568 | chromatin modification | 9 | 1017 | 145 | 25109 | 2.07e-01 | 0.01 | 0.01 | 1.5 |
1426 | | GO:0019079 | viral genome replication | 2 | 1024 | 20 | 25234 | 2.11e-01 | 0.00 | 0.00 | 2.5 |
1427 | | GO:0000902 | cell morphogenesis | 2 | 1024 | 20 | 25234 | 2.11e-01 | 0.00 | 0.00 | 2.5 |
1428 | | GO:0046620 | regulation of organ growth | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1429 | | GO:0046689 | response to mercury ion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1430 | | GO:0001935 | endothelial cell proliferation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1431 | | GO:0002037 | negative regulation of L\-glutamate transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1432 | | GO:0051222 | positive regulation of protein transport | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1433 | | GO:0033209 | tumor necrosis factor\-mediated signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1434 | | GO:0006518 | peptide metabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1435 | | GO:0033138 | positive regulation of peptidyl\-serine phosphorylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1436 | | GO:0001763 | morphogenesis of a branching structure | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1437 | | GO:0007184 | SMAD protein nuclear translocation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1438 | | GO:0031536 | positive regulation of exit from mitosis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1439 | | GO:0045321 | leukocyte activation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1440 | | GO:0051899 | membrane depolarization | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1441 | | GO:0031953 | negative regulation of protein amino acid autophosphorylation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1442 | | GO:0014070 | response to organic cyclic substance | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1443 | | GO:0046686 | response to cadmium ion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1444 | | GO:0042062 | long\-term strengthening of neuromuscular junction | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1445 | | GO:0032094 | response to food | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1446 | | GO:0006304 | DNA modification | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1447 | | GO:0030316 | osteoclast differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1448 | | GO:0006278 | RNA\-dependent DNA replication | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1449 | | GO:0007044 | cell\-substrate junction assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1450 | | GO:0048251 | elastic fiber assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1451 | | GO:0032868 | response to insulin stimulus | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1452 | | GO:0045662 | negative regulation of myoblast differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1453 | | GO:0032088 | inhibition of NF\-kappaB transcription factor | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1454 | | GO:0009620 | response to fungus | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1455 | | GO:0007625 | grooming behavior | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1456 | | GO:0042417 | dopamine metabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1457 | | GO:0016117 | carotenoid biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1458 | | GO:0006704 | glucocorticoid biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1459 | | GO:0006883 | cellular sodium ion homeostasis | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1460 | | GO:0008064 | regulation of actin polymerization and/or depolymerization | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1461 | | GO:0050860 | negative regulation of T cell receptor signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1462 | | GO:0030150 | protein import into mitochondrial matrix | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1463 | | GO:0007095 | mitotic cell cycle G2/M transition DNA damage checkpoint | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1464 | | GO:0051151 | negative regulation of smooth muscle cell differentiation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1465 | | GO:0008038 | neuron recognition | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1466 | | GO:0021675 | nerve development | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1467 | | GO:0007431 | salivary gland development | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1468 | | GO:0060158 | dopamine receptor\, phospholipase C activating pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1469 | | GO:0048545 | response to steroid hormone stimulus | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1470 | | GO:0014059 | regulation of dopamine secretion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1471 | | GO:0007210 | serotonin receptor signaling pathway | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1472 | | GO:0050710 | negative regulation of cytokine secretion | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1473 | | GO:0002011 | morphogenesis of an epithelial sheet | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1474 | | GO:0007098 | centrosome cycle | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1475 | | GO:0032228 | regulation of synaptic transmission\, GABAergic | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1476 | | GO:0035022 | positive regulation of Rac protein signal transduction | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1477 | | GO:0042420 | dopamine catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1478 | | GO:0043043 | peptide biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1479 | | GO:0001561 | fatty acid alpha\-oxidation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1480 | | GO:0021938 | smoothened signaling pathway in regulation of granule cell precursor cell proliferation | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1481 | | GO:0002726 | positive regulation of T cell cytokine production | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1482 | | GO:0042135 | neurotransmitter catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1483 | | GO:0005989 | lactose biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1484 | | GO:0045082 | positive regulation of interleukin\-10 biosynthetic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1485 | | GO:0019827 | stem cell maintenance | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1486 | | GO:0046168 | glycerol\-3\-phosphate catabolic process | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1487 | | GO:0007164 | establishment of tissue polarity | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1488 | | GO:0048706 | embryonic skeletal development | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1489 | | GO:0032981 | mitochondrial respiratory chain complex I assembly | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1490 | | GO:0006282 | regulation of DNA repair | 1 | 1025 | 5 | 25249 | 2.13e-01 | 0.00 | 0.00 | 4.9 |
1491 | | GO:0006605 | protein targeting | 3 | 1023 | 38 | 25216 | 2.15e-01 | 0.00 | 0.00 | 1.9 |
1492 | | GO:0006814 | sodium ion transport | 3 | 1023 | 158 | 25096 | 2.22e-01 | 0.00 | 0.01 | 0.5 |
1493 | | GO:0006511 | ubiquitin\-dependent protein catabolic process | 3 | 1023 | 160 | 25094 | 2.22e-01 | 0.00 | 0.01 | 0.5 |
1494 | | GO:0007266 | Rho protein signal transduction | 3 | 1023 | 39 | 25215 | 2.25e-01 | 0.00 | 0.00 | 1.9 |
1495 | | GO:0009116 | nucleoside metabolic process | 2 | 1024 | 21 | 25233 | 2.26e-01 | 0.00 | 0.00 | 2.3 |
1496 | | GO:0008380 | RNA splicing | 5 | 1021 | 224 | 25030 | 2.28e-01 | 0.00 | 0.01 | 0.5 |
1497 | | GO:0007156 | homophilic cell adhesion | 10 | 1016 | 166 | 25088 | 2.36e-01 | 0.01 | 0.01 | 1.5 |
1498 | | GO:0046907 | intracellular transport | 2 | 1024 | 22 | 25232 | 2.41e-01 | 0.00 | 0.00 | 2.2 |
1499 | | GO:0007154 | cell communication | 7 | 1019 | 114 | 25140 | 2.42e-01 | 0.01 | 0.00 | 1.5 |
1500 | | GO:0045859 | regulation of protein kinase activity | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1501 | | GO:0060088 | auditory receptor cell stereocilium organization and biogenesis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1502 | | GO:0009267 | cellular response to starvation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1503 | | GO:0048384 | retinoic acid receptor signaling pathway | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1504 | | GO:0050829 | defense response to Gram\-negative bacterium | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1505 | | GO:0043407 | negative regulation of MAP kinase activity | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1506 | | GO:0006929 | substrate\-bound cell migration | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1507 | | GO:0045069 | regulation of viral genome replication | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1508 | | GO:0031529 | ruffle organization and biogenesis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1509 | | GO:0001967 | suckling behavior | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1510 | | GO:0006356 | regulation of transcription from RNA polymerase I promoter | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1511 | | GO:0043353 | enucleate erythrocyte differentiation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1512 | | GO:0008361 | regulation of cell size | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1513 | | GO:0031397 | negative regulation of protein ubiquitination | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1514 | | GO:0046685 | response to arsenic | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1515 | | GO:0009062 | fatty acid catabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1516 | | GO:0045995 | regulation of embryonic development | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1517 | | GO:0006977 | DNA damage response\, signal transduction by p53 class mediator resulting in cell cycle arrest | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1518 | | GO:0051726 | regulation of cell cycle | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1519 | | GO:0042074 | cell migration involved in gastrulation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1520 | | GO:0006703 | estrogen biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1521 | | GO:0007089 | traversing start control point of mitotic cell cycle | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1522 | | GO:0000089 | mitotic metaphase | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1523 | | GO:0008340 | determination of adult life span | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1524 | | GO:0045197 | establishment and/or maintenance of epithelial cell polarity | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1525 | | GO:0015718 | monocarboxylic acid transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1526 | | GO:0060070 | Wnt receptor signaling pathway through beta\-catenin | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1527 | | GO:0060041 | retina development in camera\-type eye | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1528 | | GO:0051272 | positive regulation of cell motility | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1529 | | GO:0045668 | negative regulation of osteoblast differentiation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1530 | | GO:0015980 | energy derivation by oxidation of organic compounds | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1531 | | GO:0006000 | fructose metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1532 | | GO:0010043 | response to zinc ion | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1533 | | GO:0042423 | catecholamine biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1534 | | GO:0035313 | wound healing\, spreading of epidermal cells | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1535 | | GO:0042255 | ribosome assembly | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1536 | | GO:0045060 | negative thymic T cell selection | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1537 | | GO:0051605 | protein maturation via proteolysis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1538 | | GO:0006004 | fucose metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1539 | | GO:0042176 | regulation of protein catabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1540 | | GO:0032760 | positive regulation of tumor necrosis factor production | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1541 | | GO:0045351 | type I interferon biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1542 | | GO:0015807 | L\-amino acid transport | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1543 | | GO:0009101 | glycoprotein biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1544 | | GO:0007341 | penetration of zona pellucida | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1545 | | GO:0031274 | positive regulation of pseudopodium formation | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1546 | | GO:0006926 | virus\-infected cell apoptosis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1547 | | GO:0051930 | regulation of sensory perception of pain | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1548 | | GO:0006467 | protein thiol\-disulfide exchange | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1549 | | GO:0001662 | behavioral fear response | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1550 | | GO:0033014 | tetrapyrrole biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1551 | | GO:0006882 | cellular zinc ion homeostasis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1552 | | GO:0019725 | cellular homeostasis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1553 | | GO:0006875 | cellular metal ion homeostasis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1554 | | GO:0042572 | retinol metabolic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1555 | | GO:0006997 | nuclear organization and biogenesis | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1556 | | GO:0046513 | ceramide biosynthetic process | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1557 | | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1558 | | GO:0007130 | synaptonemal complex assembly | 1 | 1025 | 6 | 25248 | 2.43e-01 | 0.00 | 0.00 | 4.1 |
1559 | | GO:0006325 | establishment and/or maintenance of chromatin architecture | 3 | 1023 | 41 | 25213 | 2.46e-01 | 0.00 | 0.00 | 1.8 |
1560 | | GO:0009058 | biosynthetic process | 5 | 1021 | 76 | 25178 | 2.49e-01 | 0.00 | 0.00 | 1.6 |
1561 | | GO:0042391 | regulation of membrane potential | 2 | 1024 | 23 | 25231 | 2.55e-01 | 0.00 | 0.00 | 2.1 |
1562 | | GO:0007163 | establishment and/or maintenance of cell polarity | 2 | 1024 | 23 | 25231 | 2.55e-01 | 0.00 | 0.00 | 2.1 |
1563 | | GO:0009117 | nucleotide metabolic process | 3 | 1023 | 42 | 25212 | 2.56e-01 | 0.00 | 0.00 | 1.8 |
1564 | | GO:0007623 | circadian rhythm | 2 | 1024 | 24 | 25230 | 2.70e-01 | 0.00 | 0.00 | 2.1 |
1565 | | GO:0043085 | positive regulation of catalytic activity | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1566 | | GO:0060052 | neurofilament cytoskeleton organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1567 | | GO:0048286 | alveolus development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1568 | | GO:0007168 | receptor guanylyl cyclase signaling pathway | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1569 | | GO:0048514 | blood vessel morphogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1570 | | GO:0030147 | natriuresis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1571 | | GO:0030516 | regulation of axon extension | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1572 | | GO:0009308 | amine metabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1573 | | GO:0009605 | response to external stimulus | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1574 | | GO:0009187 | cyclic nucleotide metabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1575 | | GO:0008406 | gonad development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1576 | | GO:0016050 | vesicle organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1577 | | GO:0007599 | hemostasis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1578 | | GO:0030501 | positive regulation of bone mineralization | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1579 | | GO:0060038 | cardiac muscle cell proliferation | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1580 | | GO:0016446 | somatic hypermutation of immunoglobulin genes | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1581 | | GO:0045190 | isotype switching | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1582 | | GO:0009303 | rRNA transcription | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1583 | | GO:0007029 | endoplasmic reticulum organization and biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1584 | | GO:0042994 | cytoplasmic sequestering of transcription factor | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1585 | | GO:0046034 | ATP metabolic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1586 | | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1587 | | GO:0006207 | 'de novo' pyrimidine base biosynthetic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1588 | | GO:0042384 | cilium biogenesis | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1589 | | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1590 | | GO:0006906 | vesicle fusion | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1591 | | GO:0045749 | negative regulation of S phase of mitotic cell cycle | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1592 | | GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1593 | | GO:0006349 | genetic imprinting | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1594 | | GO:0048566 | embryonic gut development | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1595 | | GO:0006621 | protein retention in ER | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1596 | | GO:0043124 | negative regulation of I\-kappaB kinase/NF\-kappaB cascade | 1 | 1025 | 7 | 25247 | 2.73e-01 | 0.00 | 0.00 | 3.5 |
1597 | | GO:0008610 | lipid biosynthetic process | 2 | 1024 | 25 | 25229 | 2.85e-01 | 0.00 | 0.00 | 2.0 |
1598 | | GO:0007548 | sex differentiation | 2 | 1024 | 26 | 25228 | 2.99e-01 | 0.00 | 0.00 | 1.9 |
1599 | | GO:0042177 | negative regulation of protein catabolic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1600 | | GO:0050806 | positive regulation of synaptic transmission | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1601 | | GO:0006269 | DNA replication\, synthesis of RNA primer | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1602 | | GO:0030299 | cholesterol absorption | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1603 | | GO:0030595 | leukocyte chemotaxis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1604 | | GO:0051205 | protein insertion into membrane | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1605 | | GO:0043488 | regulation of mRNA stability | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1606 | | GO:0007217 | tachykinin signaling pathway | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1607 | | GO:0015991 | ATP hydrolysis coupled proton transport | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1608 | | GO:0048705 | skeletal morphogenesis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1609 | | GO:0045648 | positive regulation of erythrocyte differentiation | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1610 | | GO:0009617 | response to bacterium | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1611 | | GO:0007516 | hemocyte development | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1612 | | GO:0006548 | histidine catabolic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1613 | | GO:0007191 | dopamine receptor\, adenylate cyclase activating pathway | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1614 | | GO:0050830 | defense response to Gram\-positive bacterium | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1615 | | GO:0006323 | DNA packaging | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1616 | | GO:0001942 | hair follicle development | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1617 | | GO:0009880 | embryonic pattern specification | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1618 | | GO:0048477 | oogenesis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1619 | | GO:0048169 | regulation of long\-term neuronal synaptic plasticity | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1620 | | GO:0009435 | NAD biosynthetic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1621 | | GO:0014003 | oligodendrocyte development | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1622 | | GO:0008535 | respiratory chain complex IV assembly | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1623 | | GO:0009888 | tissue development | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1624 | | GO:0006572 | tyrosine catabolic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1625 | | GO:0042035 | regulation of cytokine biosynthetic process | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1626 | | GO:0015979 | photosynthesis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1627 | | GO:0007140 | male meiosis | 1 | 1025 | 8 | 25246 | 3.01e-01 | 0.00 | 0.00 | 3.1 |
1628 | | GO:0006310 | DNA recombination | 4 | 1022 | 58 | 25196 | 3.07e-01 | 0.00 | 0.00 | 1.7 |
1629 | | GO:0016055 | Wnt receptor signaling pathway | 6 | 1020 | 99 | 25155 | 3.07e-01 | 0.01 | 0.00 | 1.5 |
1630 | | GO:0006487 | protein amino acid N\-linked glycosylation | 2 | 1024 | 28 | 25226 | 3.28e-01 | 0.00 | 0.00 | 1.8 |
1631 | | GO:0042445 | hormone metabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1632 | | GO:0002028 | regulation of sodium ion transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1633 | | GO:0001938 | positive regulation of endothelial cell proliferation | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1634 | | GO:0045446 | endothelial cell differentiation | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1635 | | GO:0046928 | regulation of neurotransmitter secretion | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1636 | | GO:0042246 | tissue regeneration | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1637 | | GO:0007096 | regulation of exit from mitosis | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1638 | | GO:0010212 | response to ionizing radiation | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1639 | | GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1640 | | GO:0048813 | dendrite morphogenesis | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1641 | | GO:0015844 | monoamine transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1642 | | GO:0031018 | endocrine pancreas development | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1643 | | GO:0051291 | protein heterooligomerization | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1644 | | GO:0051924 | regulation of calcium ion transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1645 | | GO:0031532 | actin cytoskeleton reorganization | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1646 | | GO:0019216 | regulation of lipid metabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1647 | | GO:0007342 | fusion of sperm to egg plasma membrane | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1648 | | GO:0048812 | neurite morphogenesis | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1649 | | GO:0019228 | regulation of action potential in neuron | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1650 | | GO:0015804 | neutral amino acid transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1651 | | GO:0006892 | post\-Golgi vesicle\-mediated transport | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1652 | | GO:0006012 | galactose metabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1653 | | GO:0006308 | DNA catabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1654 | | GO:0016126 | sterol biosynthetic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1655 | | GO:0009311 | oligosaccharide metabolic process | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1656 | | GO:0050828 | regulation of liquid surface tension | 1 | 1025 | 9 | 25245 | 3.29e-01 | 0.00 | 0.00 | 2.7 |
1657 | | GO:0006885 | regulation of pH | 2 | 1024 | 29 | 25225 | 3.43e-01 | 0.00 | 0.00 | 1.7 |
1658 | | GO:0007067 | mitosis | 10 | 1016 | 181 | 25073 | 3.44e-01 | 0.01 | 0.01 | 1.4 |
1659 | | GO:0015031 | protein transport | 15 | 1011 | 487 | 24767 | 3.51e-01 | 0.01 | 0.02 | 0.8 |
1660 | | GO:0035094 | response to nicotine | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1661 | | GO:0006656 | phosphatidylcholine biosynthetic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1662 | | GO:0006066 | alcohol metabolic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1663 | | GO:0009395 | phospholipid catabolic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1664 | | GO:0040008 | regulation of growth | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1665 | | GO:0042476 | odontogenesis | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1666 | | GO:0030321 | transepithelial chloride transport | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1667 | | GO:0046785 | microtubule polymerization | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1668 | | GO:0017157 | regulation of exocytosis | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1669 | | GO:0006516 | glycoprotein catabolic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1670 | | GO:0006699 | bile acid biosynthetic process | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1671 | | GO:0007016 | cytoskeletal anchoring | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1672 | | GO:0006903 | vesicle targeting | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1673 | | GO:0008333 | endosome to lysosome transport | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1674 | | GO:0006911 | phagocytosis\, engulfment | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1675 | | GO:0007052 | mitotic spindle organization and biogenesis | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1676 | | GO:0007369 | gastrulation | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1677 | | GO:0016331 | morphogenesis of embryonic epithelium | 1 | 1025 | 10 | 25244 | 3.55e-01 | 0.00 | 0.00 | 2.5 |
1678 | | GO:0009953 | dorsal/ventral pattern formation | 2 | 1024 | 30 | 25224 | 3.57e-01 | 0.00 | 0.00 | 1.6 |
1679 | | GO:0007416 | synaptogenesis | 2 | 1024 | 30 | 25224 | 3.57e-01 | 0.00 | 0.00 | 1.6 |
1680 | | GO:0006986 | response to unfolded protein | 4 | 1022 | 67 | 25187 | 3.60e-01 | 0.00 | 0.00 | 1.5 |
1681 | | GO:0044267 | cellular protein metabolic process | 2 | 1024 | 31 | 25223 | 3.71e-01 | 0.00 | 0.00 | 1.6 |
1682 | | GO:0019226 | transmission of nerve impulse | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1683 | | GO:0050718 | positive regulation of interleukin\-1 beta secretion | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1684 | | GO:0007274 | neuromuscular synaptic transmission | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1685 | | GO:0030878 | thyroid gland development | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1686 | | GO:0006942 | regulation of striated muscle contraction | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1687 | | GO:0009396 | folic acid and derivative biosynthetic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1688 | | GO:0018279 | protein amino acid N\-linked glycosylation via asparagine | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1689 | | GO:0007088 | regulation of mitosis | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1690 | | GO:0008366 | axon ensheathment | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1691 | | GO:0009083 | branched chain family amino acid catabolic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1692 | | GO:0006479 | protein amino acid methylation | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1693 | | GO:0007224 | smoothened signaling pathway | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1694 | | GO:0048468 | cell development | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1695 | | GO:0009312 | oligosaccharide biosynthetic process | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1696 | | GO:0043588 | skin development | 1 | 1025 | 11 | 25243 | 3.80e-01 | 0.00 | 0.00 | 2.2 |
1697 | | GO:0006397 | mRNA processing | 6 | 1020 | 221 | 25033 | 3.92e-01 | 0.01 | 0.01 | 0.7 |
1698 | | GO:0007411 | axon guidance | 5 | 1021 | 82 | 25172 | 3.94e-01 | 0.00 | 0.00 | 1.5 |
1699 | | GO:0006813 | potassium ion transport | 16 | 1010 | 321 | 24933 | 3.95e-01 | 0.02 | 0.01 | 1.2 |
1700 | | GO:0048538 | thymus development | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1701 | | GO:0008156 | negative regulation of DNA replication | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1702 | | GO:0031032 | actomyosin structure organization and biogenesis | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1703 | | GO:0045664 | regulation of neuron differentiation | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1704 | | GO:0015074 | DNA integration | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1705 | | GO:0007004 | telomere maintenance via telomerase | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1706 | | GO:0006612 | protein targeting to membrane | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1707 | | GO:0001508 | regulation of action potential | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1708 | | GO:0006584 | catecholamine metabolic process | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1709 | | GO:0000045 | autophagic vacuole formation | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1710 | | GO:0006509 | membrane protein ectodomain proteolysis | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1711 | | GO:0007157 | heterophilic cell adhesion | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1712 | | GO:0031047 | gene silencing by RNA | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1713 | | GO:0006379 | mRNA cleavage | 1 | 1025 | 12 | 25242 | 4.04e-01 | 0.00 | 0.00 | 2.1 |
1714 | | GO:0009405 | pathogenesis | 3 | 1023 | 43 | 25211 | 4.27e-01 | 0.00 | 0.00 | 1.7 |
1715 | | GO:0021983 | pituitary gland development | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
1716 | | GO:0042355 | L\-fucose catabolic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
1717 | | GO:0043161 | proteasomal ubiquitin\-dependent protein catabolic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
1718 | | GO:0030514 | negative regulation of BMP signaling pathway | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
1719 | | GO:0006672 | ceramide metabolic process | 1 | 1025 | 13 | 25241 | 4.28e-01 | 0.00 | 0.00 | 1.9 |
1720 | | GO:0048015 | phosphoinositide\-mediated signaling | 3 | 1023 | 44 | 25210 | 4.31e-01 | 0.00 | 0.00 | 1.7 |
1721 | | GO:0001539 | ciliary or flagellar motility | 3 | 1023 | 47 | 25207 | 4.46e-01 | 0.00 | 0.00 | 1.6 |
1722 | | GO:0006700 | C21\-steroid hormone biosynthetic process | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
1723 | | GO:0006383 | transcription from RNA polymerase III promoter | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
1724 | | GO:0048666 | neuron development | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
1725 | | GO:0006611 | protein export from nucleus | 1 | 1025 | 14 | 25240 | 4.50e-01 | 0.00 | 0.00 | 1.8 |
1726 | | GO:0016051 | carbohydrate biosynthetic process | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
1727 | | GO:0008299 | isoprenoid biosynthetic process | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
1728 | | GO:0009165 | nucleotide biosynthetic process | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
1729 | | GO:0030100 | regulation of endocytosis | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
1730 | | GO:0042491 | auditory receptor cell differentiation | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
1731 | | GO:0006783 | heme biosynthetic process | 1 | 1025 | 15 | 25239 | 4.71e-01 | 0.00 | 0.00 | 1.6 |
1732 | | GO:0007126 | meiosis | 3 | 1023 | 53 | 25201 | 4.82e-01 | 0.00 | 0.00 | 1.4 |
1733 | | GO:0030433 | ER\-associated protein catabolic process | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
1734 | | GO:0006807 | nitrogen compound metabolic process | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
1735 | | GO:0000075 | cell cycle checkpoint | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
1736 | | GO:0007405 | neuroblast proliferation | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
1737 | | GO:0007339 | binding of sperm to zona pellucida | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
1738 | | GO:0006665 | sphingolipid metabolic process | 1 | 1025 | 16 | 25238 | 4.92e-01 | 0.00 | 0.00 | 1.5 |
1739 | | GO:0030182 | neuron differentiation | 3 | 1023 | 55 | 25199 | 4.95e-01 | 0.00 | 0.00 | 1.3 |
1740 | | GO:0051056 | regulation of small GTPase mediated signal transduction | 3 | 1023 | 57 | 25197 | 5.08e-01 | 0.00 | 0.00 | 1.3 |
1741 | | GO:0006457 | protein folding | 12 | 1014 | 242 | 25012 | 5.12e-01 | 0.01 | 0.01 | 1.2 |
1742 | | GO:0015711 | organic anion transport | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
1743 | | GO:0015914 | phospholipid transport | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
1744 | | GO:0008272 | sulfate transport | 1 | 1025 | 17 | 25237 | 5.12e-01 | 0.00 | 0.00 | 1.4 |
1745 | | GO:0007601 | visual perception | 12 | 1014 | 250 | 25004 | 5.21e-01 | 0.01 | 0.01 | 1.2 |
1746 | | GO:0007530 | sex determination | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
1747 | | GO:0007193 | G\-protein signaling\, adenylate cyclase inhibiting pathway | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
1748 | | GO:0007600 | sensory perception | 1 | 1025 | 18 | 25236 | 5.31e-01 | 0.00 | 0.00 | 1.4 |
1749 | | GO:0065002 | intracellular protein transport across a membrane | 4 | 1022 | 71 | 25183 | 5.40e-01 | 0.00 | 0.00 | 1.4 |
1750 | | GO:0006512 | ubiquitin cycle | 15 | 1011 | 444 | 24810 | 5.44e-01 | 0.01 | 0.02 | 0.8 |
1751 | | GO:0000188 | inactivation of MAPK activity | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
1752 | | GO:0007026 | negative regulation of microtubule depolymerization | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
1753 | | GO:0001709 | cell fate determination | 1 | 1025 | 19 | 25235 | 5.49e-01 | 0.00 | 0.00 | 1.3 |
1754 | | GO:0016070 | RNA metabolic process | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
1755 | | GO:0045494 | photoreceptor cell maintenance | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
1756 | | GO:0006414 | translational elongation | 1 | 1025 | 20 | 25234 | 5.67e-01 | 0.00 | 0.00 | 1.2 |
1757 | | GO:0006888 | ER to Golgi vesicle\-mediated transport | 4 | 1022 | 81 | 25173 | 5.76e-01 | 0.00 | 0.00 | 1.2 |
1758 | | GO:0019835 | cytolysis | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
1759 | | GO:0006939 | smooth muscle contraction | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
1760 | | GO:0048469 | cell maturation | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
1761 | | GO:0009966 | regulation of signal transduction | 1 | 1025 | 21 | 25233 | 5.84e-01 | 0.00 | 0.00 | 1.2 |
1762 | | GO:0006139 | nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process | 2 | 1024 | 87 | 25167 | 5.87e-01 | 0.00 | 0.00 | 0.6 |
1763 | | GO:0001541 | ovarian follicle development | 1 | 1025 | 22 | 25232 | 6.00e-01 | 0.00 | 0.00 | 1.1 |
1764 | | GO:0007223 | Wnt receptor signaling pathway\, calcium modulating pathway | 1 | 1025 | 22 | 25232 | 6.00e-01 | 0.00 | 0.00 | 1.1 |
1765 | | GO:0032259 | methylation | 1 | 1025 | 23 | 25231 | 6.16e-01 | 0.00 | 0.00 | 1.1 |
1766 | | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1 | 1025 | 23 | 25231 | 6.16e-01 | 0.00 | 0.00 | 1.1 |
1767 | | GO:0006958 | complement activation\, classical pathway | 2 | 1024 | 34 | 25220 | 6.51e-01 | 0.00 | 0.00 | 1.4 |
1768 | | GO:0009968 | negative regulation of signal transduction | 2 | 1024 | 39 | 25215 | 6.74e-01 | 0.00 | 0.00 | 1.3 |
1769 | | GO:0006367 | transcription initiation from RNA polymerase II promoter | 2 | 1024 | 40 | 25214 | 6.79e-01 | 0.00 | 0.00 | 1.2 |
1770 | | GO:0006820 | anion transport | 2 | 1024 | 40 | 25214 | 6.79e-01 | 0.00 | 0.00 | 1.2 |
1771 | | GO:0051246 | regulation of protein metabolic process | 2 | 1024 | 43 | 25211 | 6.95e-01 | 0.00 | 0.00 | 1.1 |
1772 | | GO:0042472 | inner ear morphogenesis | 2 | 1024 | 45 | 25209 | 7.06e-01 | 0.00 | 0.00 | 1.1 |
1773 | | GO:0006259 | DNA metabolic process | 2 | 1024 | 45 | 25209 | 7.06e-01 | 0.00 | 0.00 | 1.1 |
1774 | | GO:0007219 | Notch signaling pathway | 2 | 1024 | 48 | 25206 | 7.23e-01 | 0.00 | 0.00 | 1.0 |
1775 | | GO:0043087 | regulation of GTPase activity | 2 | 1024 | 48 | 25206 | 7.23e-01 | 0.00 | 0.00 | 1.0 |
1776 | | GO:0006836 | neurotransmitter transport | 1 | 1025 | 51 | 25203 | 7.24e-01 | 0.00 | 0.00 | 0.5 |
1777 | | GO:0006418 | tRNA aminoacylation for protein translation | 3 | 1023 | 61 | 25193 | 7.40e-01 | 0.00 | 0.00 | 1.2 |
1778 | | GO:0008033 | tRNA processing | 3 | 1023 | 62 | 25192 | 7.42e-01 | 0.00 | 0.00 | 1.2 |
1779 | | GO:0006812 | cation transport | 3 | 1023 | 65 | 25189 | 7.49e-01 | 0.00 | 0.00 | 1.1 |
1780 | | GO:0006821 | chloride transport | 2 | 1024 | 79 | 25175 | 7.72e-01 | 0.00 | 0.00 | 0.6 |
1781 | | GO:0006396 | RNA processing | 4 | 1022 | 90 | 25164 | 7.87e-01 | 0.00 | 0.00 | 1.1 |
1782 | | GO:0006412 | translation | 14 | 1012 | 390 | 24864 | 7.95e-01 | 0.01 | 0.02 | 0.9 |
1783 | | GO:0016192 | vesicle\-mediated transport | 11 | 1015 | 269 | 24985 | 8.77e-01 | 0.01 | 0.01 | 1.0 |
1784 | | GO:0006952 | defense response | 7 | 1019 | 181 | 25073 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
1785 | | GO:0006886 | intracellular protein transport | 14 | 1012 | 362 | 24892 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
1786 | | GO:0006913 | nucleocytoplasmic transport | 5 | 1021 | 129 | 25125 | 1.00e+00 | 0.00 | 0.01 | 1.0 |
1787 | | GO:0007264 | small GTPase mediated signal transduction | 12 | 1014 | 295 | 24959 | 1.00e+00 | 0.01 | 0.01 | 1.0 |
1788 | | GO:0008360 | regulation of cell shape | 2 | 1024 | 51 | 25203 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
1789 | | GO:0007218 | neuropeptide signaling pathway | 4 | 1022 | 108 | 25146 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
1790 | | GO:0006486 | protein amino acid glycosylation | 3 | 1023 | 81 | 25173 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
1791 | | GO:0006406 | mRNA export from nucleus | 1 | 1025 | 25 | 25229 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
1792 | | GO:0006364 | rRNA processing | 2 | 1024 | 61 | 25193 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1793 | | GO:0016338 | calcium\-independent cell\-cell adhesion | 1 | 1025 | 34 | 25220 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
1794 | | GO:0001756 | somitogenesis | 1 | 1025 | 27 | 25227 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
1795 | | GO:0015904 | tetracycline transport | 1 | 1025 | 28 | 25226 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
1796 | | GO:0046677 | response to antibiotic | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1797 | | GO:0006446 | regulation of translational initiation | 1 | 1025 | 34 | 25220 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
1798 | | GO:0006835 | dicarboxylic acid transport | 2 | 1024 | 73 | 25181 | 1.00e+00 | 0.00 | 0.00 | 0.7 |
1799 | | GO:0007059 | chromosome segregation | 1 | 1025 | 29 | 25225 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1800 | | GO:0000398 | nuclear mRNA splicing\, via spliceosome | 1 | 1025 | 41 | 25213 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
1801 | | GO:0006887 | exocytosis | 1 | 1025 | 44 | 25210 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
1802 | | GO:0006694 | steroid biosynthetic process | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1803 | | GO:0007338 | single fertilization | 1 | 1025 | 32 | 25222 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1804 | | GO:0030317 | sperm motility | 1 | 1025 | 31 | 25223 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1805 | | GO:0016071 | mRNA metabolic process | 1 | 1025 | 24 | 25230 | 1.00e+00 | 0.00 | 0.00 | 1.0 |
1806 | | GO:0032312 | regulation of ARF GTPase activity | 1 | 1025 | 30 | 25224 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1807 | | GO:0007018 | microtubule\-based movement | 4 | 1022 | 106 | 25148 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
1808 | | GO:0044237 | cellular metabolic process | 1 | 1025 | 27 | 25227 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
1809 | | GO:0007602 | phototransduction | 1 | 1025 | 26 | 25228 | 1.00e+00 | 0.00 | 0.00 | 0.9 |
1810 | | GO:0007368 | determination of left/right symmetry | 1 | 1025 | 29 | 25225 | 1.00e+00 | 0.00 | 0.00 | 0.8 |
1811 | | GO:0008654 | phospholipid biosynthetic process | 1 | 1025 | 38 | 25216 | 1.00e+00 | 0.00 | 0.00 | 0.6 |
1812 | | GO:0006270 | DNA replication initiation | 1 | 1025 | 35 | 25219 | 1.00e+00 | 0.00 | 0.00 | 0.7 |